MXPA99005029A - High moisture nutrient formulation for poultry - Google Patents
High moisture nutrient formulation for poultryInfo
- Publication number
- MXPA99005029A MXPA99005029A MXPA/A/1999/005029A MX9905029A MXPA99005029A MX PA99005029 A MXPA99005029 A MX PA99005029A MX 9905029 A MX9905029 A MX 9905029A MX PA99005029 A MXPA99005029 A MX PA99005029A
- Authority
- MX
- Mexico
- Prior art keywords
- weight
- high moisture
- group
- poultry
- spp
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 137
- 244000144977 poultry Species 0.000 title claims abstract description 93
- 238000009472 formulation Methods 0.000 title abstract description 39
- 235000015097 nutrients Nutrition 0.000 title abstract description 13
- 239000002671 adjuvant Substances 0.000 claims abstract description 42
- 230000000240 adjuvant Effects 0.000 claims abstract description 42
- 230000001186 cumulative Effects 0.000 claims abstract description 35
- 201000010099 disease Diseases 0.000 claims abstract description 17
- 230000004584 weight gain Effects 0.000 claims abstract description 11
- 235000019786 weight gain Nutrition 0.000 claims abstract description 11
- 239000003607 modifier Substances 0.000 claims abstract description 8
- 230000035882 stress Effects 0.000 claims abstract description 8
- 239000003086 colorant Substances 0.000 claims abstract description 5
- 239000000463 material Substances 0.000 claims description 193
- 241000271566 Aves Species 0.000 claims description 124
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 87
- 102000004169 proteins and genes Human genes 0.000 claims description 60
- 108090000623 proteins and genes Proteins 0.000 claims description 60
- 150000001413 amino acids Chemical class 0.000 claims description 56
- 238000000034 method Methods 0.000 claims description 46
- 150000001720 carbohydrates Chemical class 0.000 claims description 30
- 235000014633 carbohydrates Nutrition 0.000 claims description 30
- 235000013305 food Nutrition 0.000 claims description 29
- 240000008042 Zea mays Species 0.000 claims description 27
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 27
- 235000005822 corn Nutrition 0.000 claims description 26
- 235000005824 corn Nutrition 0.000 claims description 26
- 229920001817 Agar Polymers 0.000 claims description 21
- 235000010419 agar Nutrition 0.000 claims description 21
- 239000008272 agar Substances 0.000 claims description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 21
- 241000894006 Bacteria Species 0.000 claims description 19
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 19
- 229960005486 vaccines Drugs 0.000 claims description 17
- 108010078762 Protein Precursors Proteins 0.000 claims description 16
- 102000014961 Protein Precursors Human genes 0.000 claims description 16
- OZAIFHULBGXAKX-UHFFFAOYSA-N precursor Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 claims description 16
- 229920002261 Corn starch Polymers 0.000 claims description 15
- 239000000126 substance Substances 0.000 claims description 15
- 230000001580 bacterial Effects 0.000 claims description 13
- 239000008120 corn starch Substances 0.000 claims description 13
- 108010042708 Acetylmuramyl-Alanyl-Isoglutamine Proteins 0.000 claims description 12
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levotetramisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 claims description 12
- 235000013339 cereals Nutrition 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 12
- 235000013601 eggs Nutrition 0.000 claims description 12
- 210000004027 cells Anatomy 0.000 claims description 11
- BSOQXXWZTUDTEL-ZUYCGGNHSA-N muramyl dipeptide Chemical compound OC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]1NC(C)=O BSOQXXWZTUDTEL-ZUYCGGNHSA-N 0.000 claims description 11
- 108020004707 nucleic acids Proteins 0.000 claims description 11
- 150000007523 nucleic acids Chemical class 0.000 claims description 11
- 239000011780 sodium chloride Substances 0.000 claims description 11
- 230000036541 health Effects 0.000 claims description 10
- 229960001614 levamisole Drugs 0.000 claims description 10
- 239000000654 additive Substances 0.000 claims description 9
- 150000004676 glycans Polymers 0.000 claims description 9
- 239000003226 mitogen Substances 0.000 claims description 9
- 229920001282 polysaccharide Polymers 0.000 claims description 9
- 239000005017 polysaccharide Substances 0.000 claims description 9
- 150000004804 polysaccharides Polymers 0.000 claims description 9
- 210000002421 Cell Wall Anatomy 0.000 claims description 8
- 229920000057 Mannan Polymers 0.000 claims description 8
- KWIUHFFTVRNATP-UHFFFAOYSA-N Trimethylglycine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 8
- 241000700605 Viruses Species 0.000 claims description 8
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 8
- 230000001079 digestive Effects 0.000 claims description 8
- 239000000839 emulsion Substances 0.000 claims description 8
- 239000002523 lectin Substances 0.000 claims description 8
- 244000005700 microbiome Species 0.000 claims description 8
- -1 peptide Polymers 0.000 claims description 8
- 229920001184 polypeptide Polymers 0.000 claims description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- 229940113118 Carrageenan Drugs 0.000 claims description 7
- 108010062580 Concanavalin A Proteins 0.000 claims description 7
- 210000000987 Immune System Anatomy 0.000 claims description 7
- LUEWUZLMQUOBSB-GFVSVBBRSA-N Mannan Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-GFVSVBBRSA-N 0.000 claims description 7
- 239000003963 antioxidant agent Substances 0.000 claims description 7
- 235000006708 antioxidants Nutrition 0.000 claims description 7
- 235000010418 carrageenan Nutrition 0.000 claims description 7
- 239000000679 carrageenan Substances 0.000 claims description 7
- 229920001525 carrageenan Polymers 0.000 claims description 7
- 239000002158 endotoxin Substances 0.000 claims description 7
- 239000000796 flavoring agent Substances 0.000 claims description 7
- 235000019634 flavors Nutrition 0.000 claims description 7
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 7
- 235000013343 vitamin Nutrition 0.000 claims description 7
- 239000011782 vitamin Substances 0.000 claims description 7
- 229930003231 vitamins Natural products 0.000 claims description 7
- 229920000160 (ribonucleotides)n+m Polymers 0.000 claims description 6
- 102100001249 ALB Human genes 0.000 claims description 6
- HDTRYLNUVZCQOY-LIZSDCNHSA-N Trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 6
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- 239000006166 lysate Substances 0.000 claims description 6
- 230000001717 pathogenic Effects 0.000 claims description 6
- 229920001353 Dextrin Polymers 0.000 claims description 5
- 239000004375 Dextrin Substances 0.000 claims description 5
- 229920001503 Glucan Polymers 0.000 claims description 5
- 229940088597 Hormone Drugs 0.000 claims description 5
- 102000014150 Interferons Human genes 0.000 claims description 5
- 108010050904 Interferons Proteins 0.000 claims description 5
- 240000003183 Manihot esculenta Species 0.000 claims description 5
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 claims description 5
- 108010071390 Serum Albumin Proteins 0.000 claims description 5
- 230000003042 antagnostic Effects 0.000 claims description 5
- 239000005557 antagonist Substances 0.000 claims description 5
- 235000019425 dextrin Nutrition 0.000 claims description 5
- 229920000591 gum Polymers 0.000 claims description 5
- 239000005556 hormone Substances 0.000 claims description 5
- 229940079322 interferon Drugs 0.000 claims description 5
- 239000003921 oil Substances 0.000 claims description 5
- 235000019198 oils Nutrition 0.000 claims description 5
- 244000052769 pathogens Species 0.000 claims description 5
- 229960003471 retinol Drugs 0.000 claims description 5
- 150000007949 saponins Chemical class 0.000 claims description 5
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 4
- 241000700663 Avipoxvirus Species 0.000 claims description 4
- APKFDSVGJQXUKY-INPOYWNPSA-N BRL-49594 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 claims description 4
- VGGGPCQERPFHOB-MCIONIFRSA-N Bestatin Chemical compound CC(C)C[C@H](C(O)=O)NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1 VGGGPCQERPFHOB-MCIONIFRSA-N 0.000 claims description 4
- PFTAWBLQPZVEMU-DZGCQCFKSA-N Catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims description 4
- 229950001002 Cianidanol Drugs 0.000 claims description 4
- 229920002307 Dextran Polymers 0.000 claims description 4
- 231100000655 Enterotoxin Toxicity 0.000 claims description 4
- 229920002488 Hemicellulose Polymers 0.000 claims description 4
- PBJNZCQJMWVIRT-MDQYBHOLSA-N Inosine pranobex Chemical compound CC(O)CN(C)C.CC(=O)NC1=CC=C(C(O)=O)C=C1.O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C2=NC=NC(O)=C2N=C1 PBJNZCQJMWVIRT-MDQYBHOLSA-N 0.000 claims description 4
- 125000002842 L-seryl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])O[H] 0.000 claims description 4
- 125000003580 L-valyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(C([H])([H])[H])(C([H])([H])[H])[H] 0.000 claims description 4
- 229940067606 Lecithin Drugs 0.000 claims description 4
- 229920001491 Lentinan Polymers 0.000 claims description 4
- 210000002540 Macrophages Anatomy 0.000 claims description 4
- 241000700639 Parapoxvirus Species 0.000 claims description 4
- 102000004389 Ribonucleoproteins Human genes 0.000 claims description 4
- 108010081734 Ribonucleoproteins Proteins 0.000 claims description 4
- 241000194017 Streptococcus Species 0.000 claims description 4
- MPMFCABZENCRHV-UHFFFAOYSA-N Tilorone Chemical compound C1=C(OCCN(CC)CC)C=C2C(=O)C3=CC(OCCN(CC)CC)=CC=C3C2=C1 MPMFCABZENCRHV-UHFFFAOYSA-N 0.000 claims description 4
- 229950006823 Tilorone Drugs 0.000 claims description 4
- QORWJWZARLRLPR-UHFFFAOYSA-H Tricalcium phosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 4
- 229950009811 UBENIMEX Drugs 0.000 claims description 4
- PNEYBMLMFCGWSK-UHFFFAOYSA-N al2o3 Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminum Chemical class [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 4
- 229960003942 amphotericin B Drugs 0.000 claims description 4
- 230000003078 antioxidant Effects 0.000 claims description 4
- 229960003237 betaine Drugs 0.000 claims description 4
- 235000012730 carminic acid Nutrition 0.000 claims description 4
- 229920001577 copolymer Polymers 0.000 claims description 4
- 239000000147 enterotoxin Substances 0.000 claims description 4
- 229920001519 homopolymer Polymers 0.000 claims description 4
- 239000000787 lecithin Substances 0.000 claims description 4
- 235000010445 lecithin Nutrition 0.000 claims description 4
- 229940115286 lentinan Drugs 0.000 claims description 4
- 239000002502 liposome Substances 0.000 claims description 4
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims description 4
- 230000001885 phytohemagglutinin Effects 0.000 claims description 4
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims description 4
- 239000000377 silicon dioxide Substances 0.000 claims description 4
- 239000011732 tocopherol Substances 0.000 claims description 4
- 229930003799 tocopherols Natural products 0.000 claims description 4
- RPZOFMHRRHHDPZ-UHFFFAOYSA-N 1-[2-(2-cyanoaziridin-1-yl)propan-2-yl]aziridine-2-carboxamide Chemical compound C1C(C(N)=O)N1C(C)(C)N1CC1C#N RPZOFMHRRHHDPZ-UHFFFAOYSA-N 0.000 claims description 3
- 229950009664 Azimexon Drugs 0.000 claims description 3
- 241000588807 Bordetella Species 0.000 claims description 3
- 241000589562 Brucella Species 0.000 claims description 3
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims description 3
- 210000000936 Intestines Anatomy 0.000 claims description 3
- 241000588748 Klebsiella Species 0.000 claims description 3
- 241000186660 Lactobacillus Species 0.000 claims description 3
- 229940039696 Lactobacillus Drugs 0.000 claims description 3
- 210000004698 Lymphocytes Anatomy 0.000 claims description 3
- 241000237502 Ostreidae Species 0.000 claims description 3
- 235000019483 Peanut oil Nutrition 0.000 claims description 3
- 241000186429 Propionibacterium Species 0.000 claims description 3
- 241000607142 Salmonella Species 0.000 claims description 3
- 206010039447 Salmonellosis Diseases 0.000 claims description 3
- 241000191940 Staphylococcus Species 0.000 claims description 3
- 229960001295 Tocopherol Drugs 0.000 claims description 3
- 108010074506 Transfer Factor Proteins 0.000 claims description 3
- 229940088594 Vitamin Drugs 0.000 claims description 3
- 230000000996 additive Effects 0.000 claims description 3
- 230000028993 immune response Effects 0.000 claims description 3
- 239000002799 interferon inducing agent Substances 0.000 claims description 3
- 239000002480 mineral oil Substances 0.000 claims description 3
- 235000010446 mineral oil Nutrition 0.000 claims description 3
- 235000020636 oyster Nutrition 0.000 claims description 3
- 239000000312 peanut oil Substances 0.000 claims description 3
- 235000020944 retinol Nutrition 0.000 claims description 3
- 239000004576 sand Substances 0.000 claims description 3
- 239000008159 sesame oil Substances 0.000 claims description 3
- 235000011803 sesame oil Nutrition 0.000 claims description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 3
- 239000000724 thymus hormone Substances 0.000 claims description 3
- 235000010384 tocopherol Nutrition 0.000 claims description 3
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 3
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 claims description 2
- GJSURZIOUXUGAL-UHFFFAOYSA-N 2-((2,6-Dichlorophenyl)imino)imidazolidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 claims description 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K Aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims description 2
- 229960000190 Bacillus Calmette–Guérin vaccine Drugs 0.000 claims description 2
- 241001112696 Clostridia Species 0.000 claims description 2
- 108020004394 Complementary RNA Proteins 0.000 claims description 2
- 241000588722 Escherichia Species 0.000 claims description 2
- 102000015696 Interleukins Human genes 0.000 claims description 2
- 108010063738 Interleukins Proteins 0.000 claims description 2
- SFLSHLFXELFNJZ-MRVPVSSYSA-N L-Noradrenaline Natural products NC[C@@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-MRVPVSSYSA-N 0.000 claims description 2
- 229960003987 Melatonin Drugs 0.000 claims description 2
- 241001467552 Mycobacterium bovis BCG Species 0.000 claims description 2
- 229960004127 Naloxone Drugs 0.000 claims description 2
- UZHSEJADLWPNLE-GRGSLBFTSA-N Naloxone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(O)C2=C5[C@@]13CCN4CC=C UZHSEJADLWPNLE-GRGSLBFTSA-N 0.000 claims description 2
- 229960002748 Norepinephrine Drugs 0.000 claims description 2
- 102000018886 Pancreatic Polypeptide Human genes 0.000 claims description 2
- 108010052776 Pancreatic Polypeptide Proteins 0.000 claims description 2
- 241000606860 Pasteurella Species 0.000 claims description 2
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N Pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 claims description 2
- 229960001412 Pentobarbital Drugs 0.000 claims description 2
- 241000235070 Saccharomyces Species 0.000 claims description 2
- 239000001506 calcium phosphate Substances 0.000 claims description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 2
- 235000011010 calcium phosphates Nutrition 0.000 claims description 2
- 229960002896 clonidine Drugs 0.000 claims description 2
- 239000003184 complementary RNA Substances 0.000 claims description 2
- 235000021323 fish oil Nutrition 0.000 claims description 2
- 230000002401 inhibitory effect Effects 0.000 claims description 2
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 claims description 2
- 230000005012 migration Effects 0.000 claims description 2
- 235000013599 spices Nutrition 0.000 claims description 2
- 101710015954 HVA1 Proteins 0.000 claims 6
- 101700065814 LEA2 Proteins 0.000 claims 6
- 101700021338 LEC Proteins 0.000 claims 6
- 101700077545 LECC Proteins 0.000 claims 6
- 101700028499 LECG Proteins 0.000 claims 6
- 101700063913 LECT Proteins 0.000 claims 6
- 101710034340 Os04g0173800 Proteins 0.000 claims 6
- 101700036391 lecA Proteins 0.000 claims 6
- 101700001016 mbhA Proteins 0.000 claims 6
- 101700032127 ETX1 Proteins 0.000 claims 3
- 101700029730 ETX2 Proteins 0.000 claims 3
- AIHDCSAXVMAMJH-GFBKWZILSA-N Levan Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(CO[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 AIHDCSAXVMAMJH-GFBKWZILSA-N 0.000 claims 3
- 241000187654 Nocardia Species 0.000 claims 3
- 108010013639 Peptidoglycan Proteins 0.000 claims 3
- 101710023118 btfP Proteins 0.000 claims 3
- FAHBNUUHRFUEAI-UHFFFAOYSA-M Aluminium hydroxide oxide Chemical compound O[Al]=O FAHBNUUHRFUEAI-UHFFFAOYSA-M 0.000 claims 2
- 240000000218 Cannabis sativa Species 0.000 claims 2
- 108020004461 Double-Stranded RNA Proteins 0.000 claims 2
- 241000588653 Neisseria Species 0.000 claims 2
- 102100011271 Phagocytosis-stimulating peptide Human genes 0.000 claims 2
- 229940035670 Tuftsin Drugs 0.000 claims 2
- 108010084754 Tuftsin Proteins 0.000 claims 2
- IESDGNYHXIOKRW-LEOABGAYSA-N Tuftsin Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(O)=O IESDGNYHXIOKRW-LEOABGAYSA-N 0.000 claims 2
- 229920000392 Zymosan Polymers 0.000 claims 2
- 239000005482 chemotactic factor Substances 0.000 claims 2
- 230000000295 complement Effects 0.000 claims 2
- 239000011607 retinol Substances 0.000 claims 2
- 241000606790 Haemophilus Species 0.000 claims 1
- 241000186359 Mycobacterium Species 0.000 claims 1
- 210000001685 Thyroid Gland Anatomy 0.000 claims 1
- 230000004913 activation Effects 0.000 claims 1
- 239000003743 cholecystokinin B receptor antagonist Substances 0.000 claims 1
- 235000009508 confectionery Nutrition 0.000 claims 1
- 235000013360 fish flour Nutrition 0.000 claims 1
- 239000000411 inducer Substances 0.000 claims 1
- 229920001542 oligosaccharide Polymers 0.000 claims 1
- 150000002482 oligosaccharides Polymers 0.000 claims 1
- 235000013597 soy food Nutrition 0.000 claims 1
- 239000003381 stabilizer Substances 0.000 claims 1
- 230000004936 stimulating Effects 0.000 claims 1
- 150000003626 triacylglycerols Chemical class 0.000 claims 1
- 241001465754 Metazoa Species 0.000 abstract description 17
- 235000019629 palatability Nutrition 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 42
- 239000007787 solid Substances 0.000 description 41
- 235000019749 Dry matter Nutrition 0.000 description 28
- 230000012010 growth Effects 0.000 description 26
- 239000004615 ingredient Substances 0.000 description 22
- 230000000813 microbial Effects 0.000 description 22
- 235000020828 fasting Nutrition 0.000 description 21
- 240000007594 Oryza sativa Species 0.000 description 20
- 235000007164 Oryza sativa Nutrition 0.000 description 20
- 230000012447 hatching Effects 0.000 description 20
- 235000009566 rice Nutrition 0.000 description 20
- 241000287828 Gallus gallus Species 0.000 description 19
- 239000003925 fat Substances 0.000 description 19
- 235000019197 fats Nutrition 0.000 description 19
- 230000000694 effects Effects 0.000 description 18
- XBDQKXXYIPTUBI-UHFFFAOYSA-N propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 18
- 229920002472 Starch Polymers 0.000 description 16
- 235000013312 flour Nutrition 0.000 description 16
- 210000002969 Egg Yolk Anatomy 0.000 description 15
- 239000003795 chemical substances by application Substances 0.000 description 15
- 238000004519 manufacturing process Methods 0.000 description 15
- 102000004190 Enzymes Human genes 0.000 description 13
- 108090000790 Enzymes Proteins 0.000 description 13
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 13
- 235000019698 starch Nutrition 0.000 description 13
- 239000008107 starch Substances 0.000 description 13
- 230000037396 body weight Effects 0.000 description 11
- VZCYOOQTPOCHFL-OWOJBTEDSA-N (E)-but-2-enedioate;hydron Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 10
- ONFOSYPQQXJWGS-UHFFFAOYSA-N (±)-2-Hydroxy-4-(methylthio)butanoic acid Chemical compound CSCCC(O)C(O)=O ONFOSYPQQXJWGS-UHFFFAOYSA-N 0.000 description 10
- 102000011632 Caseins Human genes 0.000 description 9
- 108010076119 Caseins Proteins 0.000 description 9
- 239000005018 casein Substances 0.000 description 9
- 235000021240 caseins Nutrition 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 235000014103 egg white Nutrition 0.000 description 9
- 210000000969 egg white Anatomy 0.000 description 9
- 241000224483 Coccidia Species 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 235000010469 Glycine max Nutrition 0.000 description 8
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 8
- 239000004367 Lipase Substances 0.000 description 8
- 229940040461 Lipase Drugs 0.000 description 8
- 239000004472 Lysine Substances 0.000 description 8
- 229920000881 Modified starch Polymers 0.000 description 8
- 235000019764 Soybean Meal Nutrition 0.000 description 8
- 239000003613 bile acid Substances 0.000 description 8
- 239000008103 glucose Substances 0.000 description 8
- 235000019421 lipase Nutrition 0.000 description 8
- 102000004882 lipase Human genes 0.000 description 8
- 108090001060 lipase Proteins 0.000 description 8
- 235000016709 nutrition Nutrition 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 239000004455 soybean meal Substances 0.000 description 8
- 229940110715 ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS Drugs 0.000 description 7
- 229940020899 hematological Enzymes Drugs 0.000 description 7
- 239000003906 humectant Substances 0.000 description 7
- 229910052500 inorganic mineral Inorganic materials 0.000 description 7
- 235000010755 mineral Nutrition 0.000 description 7
- 239000011707 mineral Substances 0.000 description 7
- 230000035764 nutrition Effects 0.000 description 7
- 241000894007 species Species 0.000 description 7
- 229920001285 xanthan gum Polymers 0.000 description 7
- 240000005497 Cyamopsis tetragonoloba Species 0.000 description 6
- 229940088598 Enzyme Drugs 0.000 description 6
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 240000008529 Triticum aestivum Species 0.000 description 6
- 230000002496 gastric Effects 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 235000019260 propionic acid Nutrition 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 235000019155 vitamin A Nutrition 0.000 description 6
- 239000011719 vitamin A Substances 0.000 description 6
- 235000021307 wheat Nutrition 0.000 description 6
- 108090000695 Cytokines Proteins 0.000 description 5
- 102000004127 Cytokines Human genes 0.000 description 5
- 241000286209 Phasianidae Species 0.000 description 5
- 210000001325 Yolk Sac Anatomy 0.000 description 5
- 230000001332 colony forming Effects 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 235000013345 egg yolk Nutrition 0.000 description 5
- 239000001530 fumaric acid Substances 0.000 description 5
- 235000019426 modified starch Nutrition 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- YJISHJVIRFPGGN-UHFFFAOYSA-N 5-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy-6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol Chemical compound O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)O)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 YJISHJVIRFPGGN-UHFFFAOYSA-N 0.000 description 4
- 210000000941 Bile Anatomy 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 4
- 229940029983 VITAMINS Drugs 0.000 description 4
- 229940021016 Vitamin IV solution additives Drugs 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 238000007792 addition Methods 0.000 description 4
- 102000004965 antibodies Human genes 0.000 description 4
- 108090001123 antibodies Proteins 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 238000005755 formation reaction Methods 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 230000002458 infectious Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- 238000002255 vaccination Methods 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 3
- 240000006891 Artemisia vulgaris Species 0.000 description 3
- 208000003495 Coccidiosis Diseases 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- 240000007842 Glycine max Species 0.000 description 3
- 102000018358 Immunoglobulins Human genes 0.000 description 3
- 108060003951 Immunoglobulins Proteins 0.000 description 3
- 206010023076 Isosporiasis Diseases 0.000 description 3
- 241000194036 Lactococcus Species 0.000 description 3
- 241000288147 Meleagris gallopavo Species 0.000 description 3
- 210000004080 Milk Anatomy 0.000 description 3
- 239000004368 Modified starch Substances 0.000 description 3
- 108090000284 Pepsin A Proteins 0.000 description 3
- 108091005771 Peptidases Proteins 0.000 description 3
- 210000002381 Plasma Anatomy 0.000 description 3
- 229940082622 Prostaglandin cardiac therapy preparations Drugs 0.000 description 3
- 229940077717 Prostaglandin drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) Drugs 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 240000006394 Sorghum bicolor Species 0.000 description 3
- 229940045997 Vitamin A Drugs 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- 229940100445 WHEAT STARCH Drugs 0.000 description 3
- 230000000111 anti-oxidant Effects 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 230000003111 delayed Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drugs Drugs 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000036571 hydration Effects 0.000 description 3
- 238000006703 hydration reaction Methods 0.000 description 3
- 230000000968 intestinal Effects 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 229940094443 oxytocics Prostaglandins Drugs 0.000 description 3
- 229940111202 pepsin Drugs 0.000 description 3
- 150000003180 prostaglandins Chemical class 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 239000003760 tallow Substances 0.000 description 3
- 235000020985 whole grains Nutrition 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N (3β)-Cholest-5-en-3-ol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 235000017060 Arachis glabrata Nutrition 0.000 description 2
- 235000010777 Arachis hypogaea Nutrition 0.000 description 2
- 240000005781 Arachis hypogaea Species 0.000 description 2
- 235000018262 Arachis monticola Nutrition 0.000 description 2
- 235000007319 Avena orientalis Nutrition 0.000 description 2
- 244000075850 Avena orientalis Species 0.000 description 2
- 241000304886 Bacilli Species 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000194108 Bacillus licheniformis Species 0.000 description 2
- 240000008371 Bacillus subtilis Species 0.000 description 2
- 229940075615 Bacillus subtilis Drugs 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 229960003071 Bacitracin Drugs 0.000 description 2
- 108010001478 Bacitracin Proteins 0.000 description 2
- 210000004369 Blood Anatomy 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 240000002791 Brassica napus Species 0.000 description 2
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 2
- 206010006451 Bronchitis Diseases 0.000 description 2
- 229940043253 Butylated Hydroxyanisole Drugs 0.000 description 2
- 229940095259 Butylated Hydroxytoluene Drugs 0.000 description 2
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 2
- CZBZUDVBLSSABA-UHFFFAOYSA-N Butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 229960001091 Chenodeoxycholic Acid Drugs 0.000 description 2
- RUDATBOHQWOJDD-BSWAIDMHSA-N Chenodeoxycholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-BSWAIDMHSA-N 0.000 description 2
- 210000003278 Egg Shell Anatomy 0.000 description 2
- 210000001161 Embryo, Mammalian Anatomy 0.000 description 2
- 241000194031 Enterococcus faecium Species 0.000 description 2
- 239000004258 Ethoxyquin Substances 0.000 description 2
- 229940093500 Ethoxyquin Drugs 0.000 description 2
- DECIPOUIJURFOJ-UHFFFAOYSA-N Ethoxyquin Chemical compound N1C(C)(C)C=C(C)C2=CC(OCC)=CC=C21 DECIPOUIJURFOJ-UHFFFAOYSA-N 0.000 description 2
- 210000000416 Exudates and Transudates Anatomy 0.000 description 2
- 210000003746 Feathers Anatomy 0.000 description 2
- 235000019733 Fish meal Nutrition 0.000 description 2
- BJHIKXHVCXFQLS-UYFOZJQFSA-N Fructose Natural products OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 2
- 102100001448 GAST Human genes 0.000 description 2
- 101700005903 GAST Proteins 0.000 description 2
- 210000001035 Gastrointestinal Tract Anatomy 0.000 description 2
- 108010051696 Growth Hormone Proteins 0.000 description 2
- 102000018997 Growth Hormone Human genes 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- 229940072221 IMMUNOGLOBULINS Drugs 0.000 description 2
- 240000001046 Lactobacillus acidophilus Species 0.000 description 2
- 229940039695 Lactobacillus acidophilus Drugs 0.000 description 2
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 2
- 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 description 2
- 108090001090 Lectins Proteins 0.000 description 2
- 102000004856 Lectins Human genes 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N Linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 210000004185 Liver Anatomy 0.000 description 2
- 239000006154 MacConkey agar Substances 0.000 description 2
- 208000006758 Marek Disease Diseases 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N Methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 241000736262 Microbiota Species 0.000 description 2
- 102000035443 Peptidases Human genes 0.000 description 2
- 229940046009 Vitamin E Drugs 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- GJCOSYZMQJWQCA-UHFFFAOYSA-N Xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000012223 aqueous fraction Substances 0.000 description 2
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 2
- 230000003115 biocidal Effects 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000006161 blood agar Substances 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 229950001904 chenodiol Drugs 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 235000019621 digestibility Nutrition 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 230000002255 enzymatic Effects 0.000 description 2
- 235000019285 ethoxyquin Nutrition 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 239000004467 fishmeal Substances 0.000 description 2
- 238000001879 gelation Methods 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 235000003642 hunger Nutrition 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 239000002955 immunomodulating agent Substances 0.000 description 2
- 230000002584 immunomodulator Effects 0.000 description 2
- 229940121354 immunomodulators Drugs 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229920005610 lignin Polymers 0.000 description 2
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 2
- 244000005706 microflora Species 0.000 description 2
- 235000019713 millet Nutrition 0.000 description 2
- 235000020232 peanut Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920001592 potato starch Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 230000000529 probiotic Effects 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 239000003531 protein hydrolysate Substances 0.000 description 2
- 230000002797 proteolythic Effects 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000037351 starvation Effects 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
- 230000004083 survival Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- 150000003712 vitamin E derivatives Chemical class 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2R,3R,4S,5R,6S)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2S,3R,4S,5R,6R)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2R,3R,4S,5R,6R)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- LIFNDDBLJFPEAN-BPSSIEEOSA-N (2S)-4-amino-2-[[(2S)-2-[[2-[[2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]amino]hexanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H]1CCC(=O)N1 LIFNDDBLJFPEAN-BPSSIEEOSA-N 0.000 description 1
- WSWCOQWTEOXDQX-MQQKCMAXSA-M (E,E)-sorbate Chemical compound C\C=C\C=C\C([O-])=O WSWCOQWTEOXDQX-MQQKCMAXSA-M 0.000 description 1
- SWHSXWLSBBYLGM-UHFFFAOYSA-L 2-[(2-carboxylatophenoxy)methoxy]benzoate Chemical compound [O-]C(=O)C1=CC=CC=C1OCOC1=CC=CC=C1C([O-])=O SWHSXWLSBBYLGM-UHFFFAOYSA-L 0.000 description 1
- 101700023572 AGL Proteins 0.000 description 1
- 101710027066 ALB Proteins 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- XOYXESIZZFUVRD-UVSAJTFZSA-M Acemannan Chemical compound CC(=O)O[C@@H]1[C@H](O)[C@@H](OC)O[C@H](CO)[C@H]1O[C@@H]1[C@@H](O)[C@@H](OC(C)=O)[C@H](O[C@@H]2[C@H]([C@@H](OC(C)=O)[C@H](O[C@@H]3[C@H]([C@@H](O)[C@H](O[C@@H]4[C@H]([C@@H](OC(C)=O)[C@H](O[C@@H]5[C@H]([C@@H](OC(C)=O)[C@H](O[C@@H]6[C@H]([C@@H](OC(C)=O)[C@H](O[C@@H]7[C@H]([C@@H](OC(C)=O)[C@H](OC)[C@@H](CO)O7)O)[C@@H](CO)O6)O)[C@H](O5)C([O-])=O)O)[C@@H](CO)O4)O)[C@@H](CO)O3)NC(C)=O)[C@@H](CO)O2)O)[C@@H](CO)O1 XOYXESIZZFUVRD-UVSAJTFZSA-M 0.000 description 1
- 229960005327 Acemannan Drugs 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- WMGFVAGNIYUEEP-WUYNJSITSA-N Amylopectin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](OC[C@@H]2[C@H]([C@H](O)[C@@H](O)[C@@H](O[C@@H]3[C@H](O[C@H](O)[C@H](O)[C@H]3O)CO)O2)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H]1O WMGFVAGNIYUEEP-WUYNJSITSA-N 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 229940064005 Antibiotic throat preparations Drugs 0.000 description 1
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 1
- 229940042052 Antibiotics for systemic use Drugs 0.000 description 1
- 229940042786 Antitubercular Antibiotics Drugs 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000003826 Artemisia Nutrition 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 241000012248 Bacillus toyonensis Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 101710012512 CPM1 Proteins 0.000 description 1
- 229960004015 Calcitonin Drugs 0.000 description 1
- 102400000113 Calcitonin Human genes 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 244000132059 Carica parviflora Species 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 240000005801 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 210000004534 Cecum Anatomy 0.000 description 1
- 240000008886 Ceratonia siliqua Species 0.000 description 1
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- DJHJJVWPFGHIPH-OODMECLYSA-N Chitin Chemical compound O[C@@H]1C(NC(=O)C)[C@H](O)OC(CO)[C@H]1COC[C@H]1C(NC(C)=O)[C@@H](O)[C@H](COC[C@H]2C([C@@H](O)[C@H](O)C(CO)O2)NC(C)=O)C(CO)O1 DJHJJVWPFGHIPH-OODMECLYSA-N 0.000 description 1
- 102000009016 Cholera Toxin Human genes 0.000 description 1
- 108010049048 Cholera Toxin Proteins 0.000 description 1
- 229940107161 Cholesterol Drugs 0.000 description 1
- 229960001231 Choline Drugs 0.000 description 1
- 229960003257 Choline Citrate Drugs 0.000 description 1
- 108010003422 Circulating Thymic Factor Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000272201 Columbiformes Species 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000219748 Cyamopsis Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 description 1
- 229960000633 Dextran Sulfate Drugs 0.000 description 1
- 102000015781 Dietary Proteins Human genes 0.000 description 1
- 108010010256 Dietary Proteins Proteins 0.000 description 1
- 108010001394 Disaccharidases Proteins 0.000 description 1
- 101700033006 EGF Proteins 0.000 description 1
- 102100010813 EGF Human genes 0.000 description 1
- 102000033147 ERVK-25 Human genes 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 229940116977 Epidermal Growth Factor Drugs 0.000 description 1
- 102000003951 Erythropoietin Human genes 0.000 description 1
- 108090000394 Erythropoietin Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108010045240 FK 565 Proteins 0.000 description 1
- 102000003972 Fibroblast Growth Factor 7 Human genes 0.000 description 1
- 108090000385 Fibroblast Growth Factor 7 Proteins 0.000 description 1
- 108050007372 Fibroblast growth factor family Proteins 0.000 description 1
- 102000018233 Fibroblast growth factor family Human genes 0.000 description 1
- 229940013317 Fish Oils Drugs 0.000 description 1
- 229940064302 Folacin Drugs 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 210000003736 Gastrointestinal Contents Anatomy 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 229960004666 Glucagon Drugs 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N Glucagonum Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229940065521 Glucocorticoid inhalants for obstructive airway disease Drugs 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N Glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 229960003180 Glutathione Drugs 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229940093922 Gynecological Antibiotics Drugs 0.000 description 1
- 241001190717 Hea Species 0.000 description 1
- 240000006669 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 229960001438 IMMUNOSTIMULANTS Drugs 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102400000022 Insulin-Like Growth Factor II Human genes 0.000 description 1
- 108090001117 Insulin-Like Growth Factor II Proteins 0.000 description 1
- 102000004218 Insulin-like growth factor I Human genes 0.000 description 1
- 108090000723 Insulin-like growth factor I Proteins 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 102000000588 Interleukin-2 Human genes 0.000 description 1
- 229940047122 Interleukins Drugs 0.000 description 1
- 210000004347 Intestinal Mucosa Anatomy 0.000 description 1
- 210000001630 Jejunum Anatomy 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- XUIIKFGFIJCVMT-LBPRGKRZSA-N L-thyroxine zwitterion Chemical compound IC1=CC(C[C@H]([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-LBPRGKRZSA-N 0.000 description 1
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 1
- 229940004208 Lactobacillus bulgaricus Drugs 0.000 description 1
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 1
- 240000004403 Lactobacillus casei Species 0.000 description 1
- 229940017800 Lactobacillus casei Drugs 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 229940072205 Lactobacillus plantarum Drugs 0.000 description 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 1
- 229940001882 Lactobacillus reuteri Drugs 0.000 description 1
- 241000186604 Lactobacillus reuteri Species 0.000 description 1
- OJMMVQQUTAEWLP-KIDUDLJLSA-N Lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 description 1
- 108010074338 Lymphokines Proteins 0.000 description 1
- 102000008072 Lymphokines Human genes 0.000 description 1
- 101700010794 MAL12 Proteins 0.000 description 1
- 101700025925 MAL32 Proteins 0.000 description 1
- 101700012066 MAL62 Proteins 0.000 description 1
- 101710026950 MGAM Proteins 0.000 description 1
- 102100008175 MGAM Human genes 0.000 description 1
- 229920002521 Macromolecule Polymers 0.000 description 1
- 235000019759 Maize starch Nutrition 0.000 description 1
- 101710011129 Mal-B1 Proteins 0.000 description 1
- 235000019735 Meat-and-bone meal Nutrition 0.000 description 1
- 210000004379 Membranes Anatomy 0.000 description 1
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L MgCl2 Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 1
- 210000000110 Microvilli Anatomy 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 102000003505 Myosin family Human genes 0.000 description 1
- 108060008487 Myosin family Proteins 0.000 description 1
- 229940053128 Nerve Growth Factor Drugs 0.000 description 1
- 102000015336 Nerve Growth Factor Human genes 0.000 description 1
- 108010025020 Nerve Growth Factor Proteins 0.000 description 1
- 208000010359 Newcastle Disease Diseases 0.000 description 1
- 229940053207 Niacin Drugs 0.000 description 1
- 229920001850 Nucleic acid sequence Polymers 0.000 description 1
- 229940116542 OTHER NUTRIENTS in ATC Drugs 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 229940055726 Pantothenic Acid Drugs 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 102000026947 Plant Proteins Human genes 0.000 description 1
- 229960002429 Proline Drugs 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 229940100486 RICE STARCH Drugs 0.000 description 1
- 229960002477 Riboflavin Drugs 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- AUNGANRZJHBGPY-OUCADQQQSA-N Riboflavin Natural products OC[C@@H](O)[C@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-OUCADQQQSA-N 0.000 description 1
- 240000002547 Rosa roxburghii Species 0.000 description 1
- 235000000640 Rosa roxburghii Nutrition 0.000 description 1
- 101710024753 SERPINB14 Proteins 0.000 description 1
- 235000003534 Saccharomyces carlsbergensis Nutrition 0.000 description 1
- 229940081969 Saccharomyces cerevisiae Drugs 0.000 description 1
- 210000002374 Sebum Anatomy 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 240000002057 Secale cereale Species 0.000 description 1
- 210000002966 Serum Anatomy 0.000 description 1
- JXKPEJDQGNYQSM-UHFFFAOYSA-M Sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 description 1
- 229960003212 Sodium propionate Drugs 0.000 description 1
- 229940075554 Sorbate Drugs 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 235000019755 Starter Diet Nutrition 0.000 description 1
- 244000057717 Streptococcus lactis Species 0.000 description 1
- 235000014897 Streptococcus lactis Nutrition 0.000 description 1
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 1
- 229940037128 Systemic Glucocorticoids Drugs 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 240000005147 Syzygium aromaticum Species 0.000 description 1
- 230000024932 T cell mediated immunity Effects 0.000 description 1
- 210000001744 T-Lymphocytes Anatomy 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 108010046075 Thymosin Proteins 0.000 description 1
- 102000007501 Thymosin Human genes 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 229940036555 Thyroid hormones Drugs 0.000 description 1
- 229940034208 Thyroxine Drugs 0.000 description 1
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 1
- 231100000765 Toxin Toxicity 0.000 description 1
- 229940116362 Tragacanth Drugs 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 235000019714 Triticale Nutrition 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 208000007089 Vaccinia Diseases 0.000 description 1
- 206010046865 Vaccinia virus infection Diseases 0.000 description 1
- 102000009524 Vascular Endothelial Growth Factor A Human genes 0.000 description 1
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 1
- FEPMHVLSLDOMQC-UHFFFAOYSA-N Virginiamycin Chemical compound CC1OC(=O)C(C=2C=CC=CC=2)NC(=O)C2CC(=O)CCN2C(=O)C(CC=2C=CC=CC=2)N(C)C(=O)C2CCCN2C(=O)C(CC)NC(=O)C1NC(=O)C1=NC=CC=C1O FEPMHVLSLDOMQC-UHFFFAOYSA-N 0.000 description 1
- 229960003842 Virginiamycin Drugs 0.000 description 1
- 108010080702 Virginiamycin Proteins 0.000 description 1
- 239000004188 Virginiamycin Substances 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229940046010 Vitamin K Drugs 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 229940019697 Vitamin K containing hemostatics Drugs 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 230000003213 activating Effects 0.000 description 1
- 101700023638 aglA Proteins 0.000 description 1
- 229940050528 albumin Drugs 0.000 description 1
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007172 antigens Proteins 0.000 description 1
- 102000038129 antigens Human genes 0.000 description 1
- 235000009052 artemisia Nutrition 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000002238 attenuated Effects 0.000 description 1
- 244000052616 bacterial pathogens Species 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 230000000975 bioactive Effects 0.000 description 1
- 230000001488 breeding Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000001413 cellular Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- CRBHXDCYXIISFC-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CC[O-] CRBHXDCYXIISFC-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 229910052803 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000002939 deleterious Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000013367 dietary fats Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 235000021004 dietary regimen Nutrition 0.000 description 1
- 229940042399 direct acting antivirals Protease inhibitors Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000021271 drinking Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 229940105423 erythropoietin Drugs 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000004634 feeding behavior Effects 0.000 description 1
- 235000013332 fish product Nutrition 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000000576 food coloring agent Substances 0.000 description 1
- 239000000989 food dye Substances 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 239000000727 fraction Substances 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 239000003966 growth inhibitor Substances 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 230000003344 immunostimulant Effects 0.000 description 1
- 230000003308 immunostimulating Effects 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000000977 initiatory Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000002608 insulinlike Effects 0.000 description 1
- 229940079866 intestinal antibiotics Drugs 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 108010059345 keratinase Proteins 0.000 description 1
- 229950008325 levothyroxine Drugs 0.000 description 1
- 230000000670 limiting Effects 0.000 description 1
- 229960005287 lincomycin Drugs 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 101700009216 malA Proteins 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 150000003272 mannan oligosaccharides Chemical class 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- HOVAGTYPODGVJG-ZFYZTMLRSA-N methyl α-D-glucopyranoside Chemical compound CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HOVAGTYPODGVJG-ZFYZTMLRSA-N 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N nicotinic acid Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 230000000050 nutritive Effects 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 210000003250 oocysts Anatomy 0.000 description 1
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 description 1
- 230000021368 organ growth Effects 0.000 description 1
- 210000000056 organs Anatomy 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 210000004923 pancreatic tissues Anatomy 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- GHOKWGTUZJEAQD-ZETCQYMHSA-N pantothenic acid Natural products OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229940116317 potato starch Drugs 0.000 description 1
- 235000013324 preserved food Nutrition 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 229960002862 pyridoxine Drugs 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 230000001850 reproductive Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000717 retained Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000010334 sodium propionate Nutrition 0.000 description 1
- 239000004324 sodium propionate Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 210000004215 spores Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000006054 starter diet Substances 0.000 description 1
- 230000001954 sterilising Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000000153 supplemental Effects 0.000 description 1
- 230000002195 synergetic Effects 0.000 description 1
- 239000004577 thatch Substances 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 125000002640 tocopherol group Chemical group 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 108020003112 toxins Proteins 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 230000001131 transforming Effects 0.000 description 1
- 230000001960 triggered Effects 0.000 description 1
- 229960001322 trypsin Drugs 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 235000019373 virginiamycin Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003700 vitamin C derivatives Chemical class 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- 241000228158 x Triticosecale Species 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
Abstract
A nutrient formulation including moisture, a coloring agent, a palatability modifier, and/or an adjuvant which is designed for use in poultry and other animals, and a method of feeding it which improves subsequent livability, cumulative feed efficiency, weight gain, and resistance to disease challenge or other stresses is disclosed.
Description
FORMULATION OF HIGH MOISTURE NUTRIENTS FOR POULTRY OF CORRAL
This application is a continuation in part of the US application serial number 08 / 647,719, filed on May 24, 1996, which is a continuation in part of the US application serial number 08 / 597,815, filed on February 7, 1996, which is a continuation in part of the US application Serial No. 08 / 483,297, filed on June 7, 1995, the total contents of which are incorporated herein by reference.
BACKGROUND OF THE INVENTION The present invention is directed to a high moisture material to provide nutrients, drugs, vitamins, minerals, bile acid salts, surfactants, probiotics, enzymes, peptides, hormones, prostaglandins, antioxidants, living cells and immunoreactive agents. poultry and other animals, and more particularly, a high moisture material and a process that can be used to improve health and increase life expectancy, cumulative gain
REF: 030243 weight and feed conversion efficiency of poultry and other animals. For economic reasons, the management of chick hatch in commercial facilities places a high importance on the percentage of chicks hatched from hatched eggs. To achieve 90% shell exit ratios, birds that hatch before are often left in the incubator for a period of time to allow chicks hatch afterwards to hatch and dry. At that time, the chicks are removed from the incubator tray, therefore, these will vary in age from several hours to approximately 2 days of age (when measured from hatching for each bird). This period is referred to as the waiting period after hatching. After the chicks are removed from the incubator trays in a commercial hatchery, they are processed (inoculated and sorted by sex) and then placed in boxes commonly referred to as chick boxes for shipment to the production farm. The processing period typically requires several hours and the chicks can reside in the chick boxes for several more hours before the transit to the production farm really begins. Commercial poultry hatcheries typically provide chicks for a number of production farms, often over a wide geographical area. Typically, food and water are not provided until the birds reach the production farm and, as a result, the birds can go several days before food and water are provided. However, the presence of the yolk sac, residual, rich in lipids and lipid reserves in the liver ensure that the nutritional needs of the newly hatched birds are met (Freeman et al., Developmen t of the Avian Embryo, London, Chapman and Hall, 1974). In this way, a period of starvation after hatching in birds is normal and does not necessarily threaten their survival (Entenman et al., The Lipid Con ten t of Bl ood, Li ver, and Yolk Sac of the Newly Ha tched Chi ck and the Changes Tha t Occur in These Ti ssues During the First Mon th of Life, J. Biol Chem., Vol 133, p 231-241 (1940), Vanheel et al., Resorption of Yolk Lipids by the Pigeon Embryo, Comp. Biochem. Physiol., Vol. 68A pp. 641-646 (1981), Phelps et al., The Pos tha tch Physiology of the Turkey Poult-III, Yolk Depletion and Serum Metabolites, Comp. Biochem. Physiol., Vol. 87A, No. 2 pp. 409-415 (1987); Noble et al., Lipid Changes in the Residual Yolk and Liver of the Chick Immediately after Hatching, Biol Neonate, Vol. 56, pp. 228-236 (1989); Chamblee et al., Yolk Sac Absorption and Initiation of Growth in Broilers, Poultry Science, Vol. 72, pp. 1811-1816 (1992)). However, this does not mean that the use of a yolk residue as an individual source of nutrients in newly hatched birds will provide a subsequent, optimal life expectancy, a resistance to diseases, or a gain and feed efficiency. It has been shown that delayed placement reduces the subsequent life expectancy (Kingston, Some Hatchery Factors Involved in Early Chick Mortality, Australian Veterinary Jour., Vol. 55, pp. 418-421 (1979); Fanguy et al., Effect of Delayed Placement on Mortality and Growth Performance of Commercial Broilers, Poultry Science, Vol. 59, pp. 1215-1220 (1980)), resistance to diseases (Wyatt et al., Influence of Hatcher Holding Times on Several Physiological Parameters Associated With the Immune System of Chickens, Poultry Science, Vol. 65, pp. 2156-2164 (1986); Casteel et al., The Influence of Extended Posthatch Holding Time and Placement Density on Broiler Performance, Poultry Science, Vol. 73, pp. 1679-1684 (1994)) and growth qualities (Hager et al., Education and Production Posthatch Incubative Time and Early Growth of Broiler Chickens, Poultry Science, Vol. 62, pp. 247-254 (1983), Wyatt et al, Influence of Egg Size, Eggshell Quality, and Posthatch Holding Time on Broiler Performance, Poultry Science, Vol. 64, pp. 2049-2055 (1985), Pinchasov et al., Comparison of Post-Hatch Holding Time and Subsequent Early Performance of Broiler Chicks and Turkey Poults, British Poultry Science, Vol. 34, pp. 111-120 (1993). found that the provision of nut Individual sources such as glucose consistently or permanently improve the qualities or life expectancy when administered as a simple solution in the absence of other nutrients (Azahan et al., Growth, Food Intake and Energy Balance of Layer and Broiler Chickens Offered Glucose in the Drinking-Water and the Effect of Dietary Protein Content, British Poultry Science, Vol. 30, pp. 907-917 (1989); Moran, Effects of Posthatch Glucose on Poults Fed and Fasted During Yolk Sac Depletion, Poultry Science, Vol. 68, p. 1141-1147 (1989); Moran Effects of Egg Weight, Glucose Administration at Hatch, and Delayed Access to Feed and Wa ter on the Poul t a t 2 Weeks of Age, Poultry Science, Vol. 69, p. 1718-1723 (1990). Additional references of interest in the area of poultry nutrition and management include the following: U.S. Patent No. 1,867,063 issued to Da e, discloses a food for poultry or wet-mix livestock where the ingredients are kept at a uniform suspension in a liquid by the use of a colloidal or gel-forming material; US Patent No. 2,620,274 issued to Lewis et al. describes a poultry feed comprising an emulsion of milk solids, wheat germ solids, water, and an edible gel; U.S. Patent No. 5,217,740 issued to Lanter, discloses a high moisture ration in the form of a food article, solid, gelled, and a process for preparing it, for confined animals; PCT International Application WO 93/00017 discloses a moist food or a wet mixture having a consistency similar to oatmeal cooked with milk, semi-liquid, pourable for poultry; GB Patent 2 055 0334A issued to Nelson, discloses a method for making an animal feed of stable, liquid, emulsified wheat starch, and a stable, liquid wheat starch emulsion animal feed product produced therefrom , and contributors, Infl uen ce of Wet and Dry Feed on Laying Hen s Under Hea t S tress, Poultry Science, p. 44-52 (1991), studied the effect of two environmental temperatures on food and water consumption using four diet regimens in chickens; Thorne and collaborators, Au toma ted Hi gh Moi s t ure Di e t Feeding Sys tem for Laying Hens, Poultry Science, pp. 1114-1117 (1989), describe an automated feeding system for feeding high moisture by-product diets to laying hens by coating the surface with corn residues or methane digestive effluent on air dried food products. US Patent No. 2,946,722 issued to Hoffman et al. Describes compositions for treating poultry, which comprise a combination of sodium propionate, methyl rosanilin, ferric choline citrate, vitamin K and trace elements such as copper, zinc, cobalt, etc., and methods to use them; European Patent Application No. 0 158 075 A1 discloses immunostimulants that can be administered to animals; European Patent Application No. 0 285, 441 A3 describes immunostimulatory and synergistic compositions and methods for animals, comprising the simultaneous use of interleukin-2 and FK-565; PCT International Application WO 96/27666 describes bird cytokines and genetic sequences encoding them; finally, European Patent Application No. 0 592 220 A2 describes pharmaceutical or food compositions for animals comprising plant materials selected from Rosa roxburghii, Artemisia e argyi foli um, and Brassi ca oleracea var. capta ta ta L. Although the provision of water and food may result in qualities superior to those of water-deprived, fasting birds, attempts to include water in the incubator or transport boxes have been unsuccessful. This is because moisture control and relatively high temperature are critical in ensuring high hatchability and because simple water or simple water can escape, resulting in some chicks getting wet. Chicks can not regulate their body temperature well enough to tolerate cooling by evaporation. Since starvation does not threaten survival, commercial practice is not to offer food or water until the animals arrive on the farm.
BRIEF DESCRIPTION OF THE INVENTION Therefore, among the objectives of the invention can be observed the provision of a high moisture material to improve health and increase life expectancy, cumulative weight gain and feed conven efficiency of birds of corral and other animals. The formulation can be supplied as food, for example, immediately after hatching or the birth of the animal and by this application, the formulation preferably excludes nutrients which are not well used during the first days of life and provides those that are easily used and confer an advantage of qualities. Also among the objectives of the invention is a formulation which is stabilized against microbial growth, is resistant to syneresis and which can be packed in volume, shipped, extruded (with or without remixing before the material in volume) and divided into unit dose form at the location of use of the formulation. In summary, therefore, the present invention is directed to a process for increasing the health, life expectancy, cumulative weight gain or feed conven efficiency of poultry. The process involves feeding newly hatched birds with a high moisture material before they are initiated into a diet comprising dry feed. The newly hatched birds are fed with the high moisture material starting at a point in time preferably within the first 5 days of hatching, more preferably within the first three days of shell hatching. The high moisture material may contain a coloring agent, a flavor modifier, or an adjuvant. Whether or not an adjuvant is present, the high moisture material also increases the weight gain as well as the resistance to the problem of diseases or other tensions in the poultry. The present invention is also directed to a composition and process for innoculating poultry and other animals with living cells such as yeast or bacteria. The animal is fed with a high moisture material containing a number of units that form colonies of the cells which is sufficient to innoculate the animal and produce the desired effect. The present invention is also directed to high moisture materials to increase health, life expectancy, cumulative weight gain or feed conven efficiency of poultry.
These high moisture materials contain at least about 50% by weight of water, at least about 10% by weight of digestible carbohydrate and, optionally, one or more additional ingredients selected from the group consisting of bile acid salts, surfactants, enzymes, Enzymatic co-factors, hormones, prostaglandins, peptides, immunoglobulins, cytokines, vaccines and other immunomodulators, antioxidants, amino acids, sources of amino acids and amino acid analogs, antibiotics, vitamins and minerals. The high moisture material is preferably prepared in volume, extruded or divided into unit dosage form at the site where the high moisture material is fed to the animal. Other objects and features of the invention will be apparent in part and indicated in part hereinafter.
BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 is a graph depicting the results of Example 12. Figure 2 is a bar graph depicting the results of Example 13. Figure 3 is a bar graph depicting the results of Example 14
Figure 4 is a bar graph depicting the results of Example 15. Figure 5 is a bar graph depicting the results of Example 16. Figure 6 is a bar graph depicting the results of Example 17. Figure 7 is a bar graph depicting the results of Example 18. Figure 8 is a bar graph depicting the results of Example 19. Figure 9 is a bar graph depicting the results of Example 20.
DETAILED DESCRIPTION OF THE INVENTION Surprisingly, it has been found that poultry growth can be stimulated, life expectancy, cumulative weight gain and feed conversion efficiency of poultry can be improved by feeding the poultry with a formation of the present invention, which is referred to herein as a high moisture material. As used herein, the term "high moisture material" means a colloid in which the dispersed phase (starch, gum or protein) has been combined with the continuous phase (water) to produce a paste-like gel, viscous in which can suspend larger particles (e.g., particles greater than 5 μm in size) such as soy, corn or rice. In one embodiment of the present invention, the high moisture material is first supplied as food to freshly hatched poultry that are within five, four, three, two or even one day of hatching (as determined) for each bird). Preferably, the high moisture material is fed to the newly hatched birds before they are offered dry feed or allowed to drink water ad libitum, and more preferably before they are offered cured food, in all. The high moisture material can be placed, for example, in the incubator along with the eggs from which the poultry will hatch so that the high moisture material is available to the newly hatched birds immediately at the exit of the shell. The provision of high moisture material to chicks prior to introduction to solid feed reduces the likelihood that newly hatched birds will suffer from consuming dry feed without drinking simultaneously.
In another embodiment of the present invention, the high moisture material can be made available to newly hatched birds before or during shipment by placing the high moisture material in the chick boxes along with the chicks. According to this mode, it is preferred that the high moisture material be placed in the chick boxes before the transit starts so that the chicks will have the opportunity to consume the high humidity material before they start the trip (this is movement over the surface or air transport of the incubator site or a remote location such as a poultry production farm that may be, for example, one or more miles away from the location of the incubator). The amount of high moisture material placed in the chick boxes does not need to be sufficient to make it possible for the chicks to feed during the entire transit period. In a further embodiment of the present invention, the high moisture material is fed to the poultry after they are shipped from the site where they hatch to a remote location such as a poultry production farm or other intermediate installation. After being shipped, some chicks do not easily begin to eat dry food and drink water when offered. For such applications, it may be desirable to feed the poultry transported with the high humidity material until the poultry begins to eat dry food and to drink water ad libitum. In addition, the high moisture material may also be supplied as feed to the poultry at this time or even a time later to administer drugs or other substances as described herein. Typically, chick boxes are filled to capacity with chicks fresh from the shell, leaving little additional space for the high moisture material of the present invention. Therefore, as a practical matter, the newly hatched chicks that are in the chick boxes along with the high moisture material will stand on, will rub against, sting, and otherwise come into contact with high moisture material. Because newly hatched chicks can not regulate their body temperature well enough to tolerate cooling by evaporation, it is important that newly hatched birds do not get wet by (or become wet from) the high moisture material Under these conditions. Necessarily, therefore, the high moisture material must be resistant to syneresis under these conditions, that is, the high moisture material must not release an amount of water which is sufficient to wet the floor of the container in which the newly hatched birds are being kept or newly hatched birds as a consequence of standing on it, rubbing against it, pecking it, or otherwise coming into contact with it. When the high moisture material is initially offered to the poultry or other animal, it should contain at least about 40% by weight of water (an amount that is in excess of the amount of water contained in poultry feeds). dry "), preferably at least about 50% by weight of water, more preferably between about 50% and about 85% by weight of water, and much more preferably between about 60% and about 80% by weight of water, based on the weight of the high humidity material. The non-aqueous fraction of the high moisture material is sometimes referred to herein as the "dry matter" or the "solid matter" fraction, with the two terms being used interchangeably.
Carbohydrates provide a source of nutrition for animals, and, in addition, can help in the formation of the solid. In general, the digestible carbohydrates constitute at least about 8% by weight of the high moisture material, preferably at least about 10% by weight of the high moisture material and, for some applications, at least about 20% by weight of the material of high humidity. The digestible carbohydrates contemplated herein include isolated carbohydrates such as corn starch, potato starch, wheat starch, rice starch, cellulose, pectin, agarose and gums; bioavailable sugars such as glucose, fructose and sucrose; chemically modified starches such as modified corn starch, methylcellulose, carboxymethylcellulose and dextrin; humectants such as glycerol or propylene glycol; inverted sugar or invertase; and complex, ground carbohydrates such as corn, rice, oats, barley, wheat, sorghum, rye, millet, cassava, triticale and tapioca, in complete form, crushed, cracked, milled, rolled, extruded, pelletized, degreased, dehydrated, extracted with solvents or other processed form. When included, the preferentially modified starches constitute at least about 0.01% by weight of the high moisture material. The high moisture material is formed from a mixture of water and a combination of ingredients that makes possible the formation of a high moisture material of the mixture and that satisfies the nutrient specifications, if any. Depending on the selected ingredients, the preparation of the high moisture material may additionally require heating the mixture. In one embodiment, the mixture contains starch and is heated until the starch granules are broken and the mixture becomes viscous. See, for example, U.S. Patent No. 2,593,577 issued to Lewis. In another embodiment, the high moisture material is formed from a colloidal solution containing a gum dissolved in water; some gums make possible the formation of high moisture materials of the colloidal solution without heating while others require the solution to be heated to a temperature in excess of about 82 ° C (180 ° F). In general, the gums may constitute about 0.001% to about 5% by weight of the high moisture material. The gums which can be used for this purpose are generally high molecular weight molecules of vegetable or animal origin, usually with colloidal properties, which in suitable solvents are capable of producing gels, such as agar, algin and carrageenan derived from seaweed, plant exudates such as gum arabic, ghatti and tragacanth, plant extracts such as pectin, plant seeds such as guar (Cyamopsi s te tra gonol oba), carob and animal exudates such as plasma, serum albumin, egg albumin , chitin and gelatin. Other gums include amylose and amylopectin and gums of bacterial origin. See, for example, U.S. Patent No. 5,217,740. In yet another embodiment, a gelatinization aid such as carboxymethylcellulose, lignin or a lignin derivative is dissolved in water to form a colloidal solution that forms a gel upon cooling. After the ingredients of the high moisture material are mixed and heated (if necessary), the material can be left to form a gel in situ, transferred to another vessel or container for storage in a bulky form, or cast in a form and size that makes possible the convenient feeding for the animals. In a preferred embodiment, the mixture can be transferred to a container such as a drum or a deformable plastic which maintains, for example, between about 25 and about 1,000 kilograms of the high moisture material. For administration to freshly hatched poultry, the high moisture, pre-gelled material has a texture that makes it possible for newly hatched birds to break the high moisture material into pieces by pecking it.; that is, the high humidity material is sufficiently soft that the pecking of newly hatched birds will cause the high moisture material to break or crumble into consumable fragments. However, once it breaks into fragments, the high moisture material preferentially does not adhere to the feathers or down freshly hatched poultry. In addition, it is preferred that the high moisture material comprises particles that are visible to the naked eye. Such particles include, for example, ground ingredients such as ground grains and seeds such as corn and soybeans, and other particles that do not exceed the size of a typical grain of white rice (i.e., about 1 mm). Unless the high moisture material is fed quickly to an animal, it is preferably stabilized against microbial growth. That is, by being sealed and stored at room temperature for a period of at least about eight weeks the high moisture, stabilized material will show no indication of microbial growth. The high moisture material can be stabilized, for example, by sterilization, the addition of a microbial growth inhibitor such as methyl paraben or a sorbate thereto, or the pH adjustment of the mixture from which the material is formed. of high humidity. Preferably, the high moisture material is stabilized by adjusting the pH of the mixture with an acid at a pH within the range of about 3 to about 4, more preferably at a pH within the range of about 3 to 3.5. Such an acid may be a low molecular weight carboxylic acid, preferably having a C: -Cio chain length, more preferably having a chain length of C2-C-7, more preferably having a chain length of C2 - C5. Examples of useful carboxylic acids include citric acid, propionic acid and fumaric acid. You can also use phosphoric acid. The propionic acid may be present in an amount of about 0.5% to about 1% by weight of the present high moisture material; citric acid and fumaric acid may be present in an amount of about 0.7% to about 2% by weight of the high moisture material. High moisture material can be supplied as food to animals in a variety of ways. For example, the amount required for feeding may be scooped, cut, or otherwise removed from the unit, vessel, or pouch in which it is maintained and transferred to the animal (s) in a unitary manner. However, to reduce work, unit doses of the solid can be generated from the bulky material by pumping or compressing the high moisture material and forcing it through an opening. The resulting material, referred to herein as an extruded material, is in the form of a high moisture material that contains substantially the same amount of water as the bulky material. In one embodiment, the high moisture material may be in a compressible container which is compressed to force the high moisture material to flow through a nozzle and into a location where it can be consumed by the animal (s). In some examples, it may be preferred to combine the high moisture material with a labile, hot ingredient or other ingredient before the high moisture material is supplied as food to the animal (s); In these examples, the labile, hot ingredient is added to the high moisture material at or near room temperature and the total mixture is then remixed before being divided into unit doses. Alternatively, the hot, labile material can be sprayed on the unit dose of the high moisture material. However, in any case, the extrusion step should not cause the high moisture material to lose a significant amount of water or the desired texture. This is, the extruded material must preferably contain at least 40% by weight of water, preferably at least about 50% by weight of water, more preferably between about 50% and about 85% by weight of water, and in much more preferably between about 60% and about 80% by weight of water, based on the weight of the extruded material and, in addition, the extruded material must be sufficiently smooth such that the pecking of newly hatched birds causes the material High moisture breaks or crumbles into consumable fragments. The high moisture material of the present invention resists syneresis when it contains at least about 5% protein. To increase its nutritive value for some applications such as long-term feeding, the high moisture material preferably comprises at least about 7% by weight, more preferably at least about 10% by weight of an amino acid source such as protein (s), amino acid precursors or amino acid analogs, and mixtures thereof. Furthermore, it is preferred that the weight ratio of all the digestible carbohydrate to all amino acid sources in the high moisture material be between about 0.6: 1 and 3: 1, respectively. Exemplary amino acids are essential amino acids such as methionine, tryptophan, threonine, arginine and lysine. Exemplary amino acid precursors are 2-hydroxy-4- (methylthio) butanoic acid sold, for example, under the trademark Alimet by Novus International (St. Louis, MO), and salts of 2-hydroxy-4- (methylthio) acid ) butanoic such as the calcium and sodium salts. Exemplary proteins include proteins from individual cells or hydrolyzed proteins such as those from yeast, algae or bacteria; proteins from isolated animals, peptides or protein hydrolysates such as hemoglobin, myosin, plasma or other whey proteins, collagen, casein, albumin or keratin; Protein sources complex or hydrolyzed proteins such as milk, blood, whey, blood powder, meat powder, feather meal, fish meal, meat and bone meal, offal of poultry, flour derived from poultry, hatchery derivatives, egg scraps, egg white, egg yolk and eggs without eggshells; plant protein or protein hydrolyzate such as soybean meal, isolated soy protein, wheat protein, wheat germ, grain distillers and gluten. Although not preferred for certain applications, grease can also be included in the high moisture material in relatively small proportions. Therefore, a suitable high moisture material would comprise at least about 50% by weight of water and not more than about 5% by weight of fat, preferably not more than about 4% by weight of fat. Suitable fats include fatty acids such as linoleic acid; oils isolated from plants such as sunflower, safflower, soybean, peanut, cañola, corn, naba or rape seed, olive, flaxseed and palm kernel; greasy flours such as cottonseed, peanut, naba or rape seed, palm flour and walnut flours; and fats of animal origin such as egg yolk, lard, butter, poultry fat, tallow and fish oil. The various processes described herein may employ different types of high moisture materials depending on the particular application. These high moisture materials may contain: between about 50% and about 80% by weight of water; at least about 10% by weight of carbohydrate; and a member selected from the group consisting of: at least about 5% by weight of protein, at least about 7% by weight of amino acids, amino acid precursors, amino acid analogs or a combination thereof, a combination of at least about 5% by weight of protein and at least about 5% by weight of amino acids, amino acid precursors, amino acid analogues or a combination thereof, a combination of at least about 10% by weight of protein, amino acids, amino acid precursors and amino acid analogues, and at least about 10% by weight of protein. The ratio of carbohydrates to the various nitrogen containing members in those high moisture materials may be in the range between about 1: 1 and about 3: 1. When the high moisture material contains at least about 7% by weight of amino acids, amino acid precursors, amino acid analogs, or a combination thereof, or a combination of at least about 10% by weight of protein, amino acids, precursors of amino acids, and amino acid analogs, the high moisture material may also contain a starch, a gum or a combination thereof. The starch can be an unmodified starch or a combination of an unmodified starch and a modified starch. When the starch is an unmodified starch, it may be present in an amount of at least about 10% by weight. When the starch is a combination of an unmodified starch and a modified starch, the modified starch may be present in an amount of at least about 0.01% by weight. When a gum is employed, it may be present in an amount of about 0.001% to about 5% by weight. To make it possible for newly hatched birds to use more effectively any fat that may be present in the high moisture material or to enable newly hatched birds to more effectively use their lipid and protein based on the yolk, the High humidity material may contain bile acid salts, cholesterol, surfactants, emulsifying agents, micelles, or an enzyme such as lipase, amylase, maltase, pepsin, trypsin or other enzyme which commonly occurs in the gastrointestinal system, or an enzyme such as keratinase which is not typically found in the gastrointestinal system but which has useful activities. The concentration of the digestion aid will depend on the application but, in general, it will be between about 0.01% and about 5% by weight of the dry matter. The high moisture material may additionally contain vitamins and minerals. The vitamin additives can be selected, for example, from vitamin A, B12, biotin, choline, folacin, niacin, pantothenic acid, pyridoxine, riboflavin, thiamine, C, D, 25-hydroxy, D, E and K. The additives Minerals can be selected, for example, from calcium, phosphorus, selenium, chloride, magnesium, potassium, sodium, copper, iodine, iron, manganese and chromium pincolinate. The concentration of the vitamins and minerals will depend on the application but, in general, it will be between approximately 0.01% and approximately 5% by weight of the dry matter.
Bacterial, yeast or mold preparations, commonly referred to as probiotics or direct-feeding microbes, have been administered orally or have been added to animal feeds to provide various benefits such as altering the gastrointestinal microflora / microbiota of poultry. corral and other animals. These microbial additives which have been approved for use are identified in the annual Feed Additive Compendium published by The Miller Publishing Company (Minnetonka, MN) in cooperation with The Animal Health Institute and the Direct-fed Microbial, Enzyme and Forage Additive Compendium published by The Miller Publishing Company. Among the direct-feeding microbial agents which have been approved are strains of lactic acid bacteria, particularly those classified in the following genera: Lactobacillus, Lactococcus, and Enterococcus. Included among these are the following species: Lactobacillus reuteri, Lactobacillus acidophilus, Lactobacillus bulgaricus, Lactobacillus plantarum, Lactobacillus casei, Lactobacillus lactis, Lactococcus lactis, Lactococcus thermophilus, Lactococcus diacet ylactis, and Enterococcus faecium. In addition to these lactic acid bacteria, some species of Bacillus (such as Bacillus subtilis and Bacillus toyoi), some species of Streptococcus (such as Streptococcus faecium), and yeasts and molds (such as Saccharomyces cerevisiae, Aspergillus oryzae, and Torulopsis sp. ) have also been used as direct feeding microbial agents. Therefore, the high moisture material of the present invention can be used as a vehicle for administering direct feeding microbial agents to poultry or other animals. When used for this purpose, the high moisture material should contain enough colony-forming units of the yeast or bacteria that is of benefit to the animal. In general, the high moisture material used as a direct feed microbial agent should contain at least about 102, preferably about 10"5, and most preferably about 106 colony forming units of bacteria or at least about 10, preferably about 10 2, and most preferably about 104 yeast colony forming units per gram of composition.The yeast or bacteria can be incorporated into the high moisture material before solidification or can be deposited on or in the High moisture material after it has solidified.
Although the high moisture material can be supplied as food at any time to alter the gastrointestinal microflora / microbiota of or provide other benefits to the animal, it is preferably fed to poultry as soon as possible after the exit of the animal. shell to establish the direct feeding microorganism (s) as the dominant flora or culture in the gastrointestinal tract and thereby exclude potential pathogens. The high moisture material can additionally be used as a vehicle to supply a variety of other substances to poultry and other animals. For example, the high moisture material may contain a peptide such as epidermal growth factor, transformation growth factor, granulocyte-macrophage colony stimulation factor, erythropoietin, esin, fibroblast growth factor, keratinocyte growth factor. , nerve growth factor, vascular endothelial growth factor, bovine growth factor or other somatotropin or insulin-like factor (IGF-I or IGF-II). The high moisture material may also contain a steroid or polypeptide hormone such as estrogen, glucocorticoids, insulin, glucagon, gastrin, calcitonin or somatotropin. The high moisture material may additionally contain an antibiotic approved for use in animal feed such as bacitracin, BMD (bacitracin methylendisalicylate), lincomycin, or virginiamycin or other therapeutic drug. The high moisture material may also additionally contain a natural or synthetic antioxidant such as ethoxyquin, tocopherol, BHT (butylated hydroxytoluene), BHA (butylated hydroxyanisole), vitamin C or glutathione; a receptor, transfer factor, chelating agent or a complexing agent that modifies the rates of release of nutrients or other bioactive compounds; an immunoactive agent such as cytokines, vaccines and other immunomodulators, immunoglobulins, antigens, dead cells, attenuated strains, toxins, or adjuvants; or a flavor modifier or an uptake regulator such as food dyes, grains of sand, oyster shell or shell, seeds or whole grains. These substances can be used alone or in combination with others. The concentration of these additives will depend on the application but, in general, will be between about 0.0001% and about 10% by weight of the dry matter, more preferably between about 0.001% and about 7.5%, more preferably between about 0.01. % and approximately 5%. Food colorants useful in the present invention include, for example, red, green, blue, blue-green, black and beige. Substances useful as flavor modifiers or uptake regulators in addition to those mentioned above include the t-glycerides; fish products such as fish meal and fish oils; spices such as sage or mugwort, thyme, cloves, etc .; clonidine; hydrolysed gums and gums such as guar gum, xanthan gum, algin, etc .; gastrin antagonists; cholecystocin antagonists; amino acids such as methionine, tyrosma, ferulalamine, etc .; naloxone; pancreatic polypeptide; norepinephrine; melatonin antagonists; Thyroid hormones such as thyroxine, T3, T4, etc .; and pentobarbital. Adjuvants that can be incorporated into the high moisture material can be of several different types, for example, microbiologically derived substances, viruses, lectins, polysaccharides, oils, peptides, polypeptides and proteins, and various nucleic acids. Microbiologically derived substances include materials produced by, or which are cellular components of, microorganisms such as bacteria, fungi such as yeasts, etc. Prior to the present investigations, it was not known that such substances could be used as orally effective adjuvants in poultry to stimulate the immune system and / or to increase the resistance of poultry to pathogens or other stresses, including exposure to heat or cold, dehydration, ammonia fumes in bed or straw, transport, etc. Similarly, it was not previously known that such adjuvants, when administered orally, could positively affect the health, life expectancy, weight gain or feed conversion efficiency of poultry. The microbiologically derived adjuvants comprise a variety of different types of substances. For example, these may include lysates of -bacteria such as Ha emophillus sp., Dipl ococcus sp., Nei sseri a sp., Etc .; 6, 6-diesters of trehalose (cord factor) and synthetic analogs thereof; muramyl dipeptide (N-acetyl-muramyl-L-alanyl-D-isoglutamine) and synthetic analogs thereof; L-seryl and L-valyl derivatives of muramyl dipeptide;
dead bacteria and derivatives thereof such as Escherichia spp, Clostridia spp, Salmonella spp, Lactobacillus spp, Streptococcus spp, Bacillus Calmette-Guerin, Micobacterium spp, Bordetella spp, Klebsiella spp, Brucella spp, Propionibacterium spp such as Corynebacterium parvum, Pasteurella spp , Norcardia spp such as Norcardia rubra and derivatives thereof such as water-soluble mitogen Norcadia; Staphylococcus cell wall products; bestatin; dead yeast such as Saccharomyces spp and Candida spp .; yeast derivatives such as cimosan, glucan and lentonin; endotoxins and enterotoxins such as cholera toxin; cell wall peptides-glycans; and bacterial ribonucleoproteins. Microbiologically derived adjuvants also include viruses, for example Avipoxvirus and Parapoxvirus. Useful lectins include, for example, concanaval ina A, carmine or grana herb mitogen, and phytohemagglutinin. Useful polysaccharides include mannans such as acemannan, acetylated mannan linked in β- (1, 4), and mannan oligosaccharide; glucans; carrageenan and carrageenan iota; hemicelluloses; levans; agar; tapioca; dextrins; dextrans, for example dextran sulfate salts of various molecular weights; and lipopol isaccharides.
Oily emulsions useful as adjuvants can be produced using mineral oil, peanut oil, and sesame oil, for example. Useful peptides and macromolecules include cytokines such as lymphokines, interleukins, Transfer Factor, Macrophage Activating Factor, Migration Inhibitory Factor and mitogenic factors for lymphocytes; digestive substances of nucleic acid; interferon and interferon inducers such as BRL 5907; double-stranded, complementary RNA homopolymers such as poly I: C and poly A: U; Immune RNA; thymus hormones such as timostimulin, thymulin, thymosin and t imopoyet ina; protease inhibitors; chemostatic factors for macrophages and other cells; tuftsina; and serum albumin (bovine, human, acetylated derivatives, globules, etc.). Finally, a variety of other substances that can be employed as adjuvants in the present invention include saponins such as QuilA and Iscoms; thiabenedezol; tilorone; estatolone; maleic anhydride-divinyl ether; pyran copolymers; amphotericin B; liposomes; silica; calcium phosphate; glycerol; betaine; protodine; cyanidanol; imutiol; picibanil; isoprinosine; lentinan; azimexon; lecithin; levamisole; vitamin A and other retinols; vitamin E and other tocopherols; antioxidants such as ethoxyquin; aluminum salts, such as sulfates and phosphates, including alum (KAl (S04) 2-12H20); aluminum hydroxide; and aluminum oxide. Vaccines useful in the present invention include those effective against diseases common in poultry such as Newcastle Disease, Marek's Disease, infectious cavity disease, infectious bronchitis, enteritis, coccidiosis, etc. These vaccines include the Newcastle vaccine, Marek's disease vaccine, vaccinia for infectious cavity disease, vaccine for infectious bronchitis and CocciVac, for example, when used in conjunction with the high moisture material of the present invention. , these vaccines can be administered to young birds within 0 to about 10 days from hatching, orally, by injection of yolk sac, subcutaneously, in ovo, or by inhalation through mist or spray. formulation that satisfies the nutrient specifications of the high moisture material of the present invention can be prepared, for example, from the following mixture of ingredients (based on the weight of the non-aqueous fraction of the high moisture material): soybean meal 58 Dry egg white% corn starch 4% corn flour 30% Alimet® 0.5% propionic acid 0.5% citric acid for pH 3.5 - 4
High moisture materials containing these ingredients (and optionally one or more of the other additives described herein) can be made by dry blending the ingredients, add hot water (80 ° C) and quickly mix the moistened ingredients while maintaining the temperature above the gelation temperature of the starch for at least one minute. The mixture is then stirred and pressed into a plate, cylinder, mold or other container or container. Although a high moisture material can be prepared from a starter diet formulation for poultry, such simple mixtures readily allow the escape of free water that is potentially deleterious. The newly hatched chicks could not only suffer from evaporative cooling as a result of being moistened by the moisture released, they could suffer from the consumption of high moisture material that contains insufficient moisture. In addition, a loss of moisture could cause a substantial change in the texture of the high moisture material, changing it from a material which the newly hatched chicks can break into parts by snacking and consuming one which is hard or "rubbery" and inaccessible to birds. Therefore, it is preferred that the high moisture material have an initial moisture content of at least about 40% by weight of water and that the high moisture material retains substantially all of its water under the conditions in which it must be provided to the chicks. More preferably, the high moisture material will retain at least 80% and more preferably at least about 90% of its water content when exposed to a temperature of 80 ° C and a relative humidity of 70% for 24 hours. . To improve the water retention capacity of the high moisture material, humectants, gums, proteins or other ingredients may be included in the formulation. Similarly, the digestibility of the ingredients could be improved with additions to the formulation such as, but not limited to, enzymes, bile acid salts or surfactants. Similarly, the total qualities can be improved with the addition of selected micro-ingredients, minerals, microorganisms, growth promoters, hormones, prostaglandins such as E2 or other factors that promote enhanced, digestive enzymatic activity, nutrient absorption or maturation of the gastrointestinal system as a whole. In general, highly available protein sources could include hydrolyzed protein for poultry, hydrolyzed casein, or peptone. In contrast, less available protein sources such as by-product flours or vegetable proteins could be provided as foods in combination with factors such as proteases or microorganisms that secrete proteases to increase disgestibility. Similarly, carbohydrates such as glucose can be selected for high availability or more complex sources such as ground corn or potato starch can be supplemented with enzymes or can be subjected to gelation to increase their availability. The digestibility of saturated fats could be improved through the addition of lipase, bile acid salts or surfactants. In this way, the formulation would include either highly available ingredients or additives or management methods that improve the digestion of ingredients less available in very young birds. The ingredients would be administered in a semi-solid or solid form. In addition, it has been shown that the gastrointestinal system of young birds is not able to use certain ingredients such as sebum with the same efficiency as mature birds (Fredde et al., Factors Affecting the Absorbability of Certain Dietary Fats in the Chick, J. Nutrition, Vol. 70, pp. 447-452 (1960); Gómez et al., The Use of Bile Salts to Improve Absoption of Tallow in Chicks, One to Three Weeks of Age, Poultry Science Vol. 55, pp. 2189-2195 (1976); Polin et al., The Effect of Bile Acids and Lipase on Absorption of Tallow in Young Chicks, Poultry Science, Vol. 59, pp. 2738-2743 (1980); Sell et al., Influence of Age on Utilization of Supplemental Fats by Young Turkeys, Poultry Science, Vol. 65, pp. 546-554 (1986)). The ontogenetic changes accompanying enhanced digestion include increased levels of pancreatic and intestinal enzymes (Krogdahl et al., Influence of Age on Lipase, Amylase, and Protease Activities in Pancreatic Tissue and Intestinal Contents of Young Turkeys, Poultry Science, Vol. 68, pp. 1561-1568 (1989), Sell et al, Intestinal Disaccharidases of Young Turkeys: Tempral Development and Influence of Diet Composition, Poultry Science, Vol. 68, pp. 265-277 (1989); Noy et al., Digestion and Absorption in the Young Chick, Poultry Science, Vol. 74, pp. 366-373 (1995)), the surface area of the total intestines for absorption (Nitsan et al., Growth and Development of the Digestive Organs and Some Enzymes in Broiler Chicks Adter Hatching, British Poultry Science, Vol. 32, pp. 515-523 (1991); Nitsan et al., Organ Growth and Digestive Enzyme Levéis to Fifteen Days of Age in Lines of Chickens Differing in Body Weight, Poultry Science, Vol. 70, pp. 2040-2048 (1991); Sell et al., Developmental Patterns of Selected Characteristics of the Gastrointestinal Tract of Young Turkeys, Poultry Science, Vol. 70, p. 1200-1205
(1991)), and changes in nutrient transporters
(Shehata et al., Development of Brush-Border
Membrane Hexose Transport System in Chick Jejunum, Am.
J. Physiol, Vol. 240, pp. G102-F108 (1981); Buddington et al., Ontogenetic Development of Intestinal Nutrient Transporters, Annu. Rev. Physiol., Vol. 51, pp. 601-619 (1989); Moreto et al., Transport of L-Proline and a-Methyl-D-Glucoside by Chicken Proximal Cecum During Development, Am. J. Physiol, Vol. 260, p. G457-G463 (1991)). The high moisture materials of the present invention would minimize or exclude poorly utilized ingredients and replace the most highly available ingredients as assessed by the subsequent qualities of the birds. The amount of high moisture material supplied as food will be a function of the species of the animal, age, environmental conditions such as temperature and humidity and, in the case of poultry, the length of the preset period, ie, the time total consumed in the waiting period after hatching, the processing period and in transit to the poultry production farm. However, in general, at least approximately 5 grams of high moisture material per chick per day should be provided to chicks 0 to 2 days old, approximately 10 grams of high moisture material per chick per day should be provided. chicks 2 to 3 days old, and up to about 20 grams of high moisture material per chick per day should be provided to chicks 4 to 7 days old. As previously observed, the chicks are conventionally placed in the poultry production farms within approximately 2 days of hatching. This practice has been developed, in part, outside the fact that incubators typically do not provide food or water to newly hatched birds and the fact that newly hatched birds must receive water and a source of nutrition for approximately 3 days. or also that they suffer. Because the composition of the high moisture materials of the present invention can be controlled to meet the change in nutritional requirements of newly hatched birds as they mature, it can become practical for incubators to retard sending the chicks to the poultry production farms for a longer period of time or to ship the chicks a greater distance without experiencing many of the difficulties associated with providing water and chick nutrition. In this way, for example, the incubators could conveniently feed the high moisture material of the present invention to the chicks for a period of about 3 to about 7 days from hatching before shipping them to the production farms. poultry. Alternatively, the chicks could be shipped from the incubator to an intermediate facility where they could be fed with the high humidity material for a period of time. period of approximately 7 days and then be shipped to the poultry production farm, normal. Any proposal would allow poultry production farms to use their buildings more efficiently without the incubators being concerned about feeding freshly hatched birds with water and dry feed. The following examples will illustrate the invention.
EXAMPLE 1 The qualities of birds from 1 to 4 days of age, that is, birds that were no less than 1 day old and no more than 4 days old at the start of the test when measured from hatching to each bird, fed with high moisture solids consisting of agar (1.5% agar and 98.5% water weight) or agar and egg yolk (1.5% agar, 10% egg yolk and 88.5% weight water) were compared to fasting and water-deprived birds. The results are presented in Table 1. Birds initially lost weight in all feeding regimens and agar alone did not give benefit in either cumulative gain or cumulative feed-to-cumulative gain ratio ("FTG"). The agar plus the yolk showed an effect on the cumulative gain on days 6 and 13, but the cumulative feed-to-gain ratio (sometimes referred to herein as cumulative feed efficiency) was poorer than for fasting birds. The data also suggest that hydration alone
(agar treatment) with or without yolk did not confer cumulative feeding efficiency benefit in this study. The cumulative life expectancy was improved by feeding with any formulation containing water.
TABLE 1
Growth of Non-Fed Birds or Formulations Consisting of Agar (1.5%) with or without Egg Yolk (10%)
> - - l
EXAMPLE 2 In this example, groups of birds from one to four days old were fed for 24 or 48 hours with a high moisture solid consisting of starter feed and water. The cages were given enough solid of high humidity for each bird to consume 10 g. The food was presented in either 25, 50 or 100% of the high moisture solid. From Table 2 it appears that the high moisture solid containing 25% dry matter gave the best cumulative gain after feeding for either 24 or 48 hours. However, it should be noted that all high moisture solids showed cumulative gain higher than fasting controls. When the cumulative feed efficiency was corrected for differences in body weight (BW FTG), the high humidity solid of 25% dry matter was again superior to the others provided as food either for 24 or 48 hours. The uptake of the cumulative feed subsequent to the 48-hour treatment period was higher when the high-moisture solid birds were given than when they were fasting. This was the case for formulations containing 25, 50 or 100% dry matter. Cumulative life expectancy data suggest that high moisture solids containing a higher percentage of dry matter are associated with lower life expectancy than fasting control or formulations with 25% dry matter.
TABLE 2 Growth of Birds Fed with Food Starter and Wet Combinations
EXAMPLE 3 In this example, groups of birds from one to four days old were given 20 g each of a high moisture solid consisting of a gelatin base and Alimet® (2-hydroxy-4- ( methylthio) butanoic) with additions of either corn starch or corn starch and lysine. The dry matter content of the high moisture solid was about 5% and the amount of each of the constituents of the dry matter, based on the weight of the high moisture solid for each formulation, was as indicated in Table 3. The formulation containing corn starch, gelatin and Alimet® showed a cumulative gain and life expectancy superior to fasting control and the other two formulations. Treatments 2 and 3 also showed uptake of the cumulative diet, higher when compared with the fasting control, but the formulations tended to melt at the hatching temperature which could cause problems in the hatching and transit of the boxes.
TABLE 3 Growth of Birds Fed with Formulations Containing Starch, Gelatin, Alimet and Lysine Combinations
Ui
EXAMPLE 4 Groups of birds from one to four days of age were fed formulations containing fat and protein sources administered with or without added lipase to aid in the digestion of fat. All the formulations contained corn starch, Alimet, lysine and the salt of bile acid, chenodeoxycholic acid. In case one, the protein and fat were provided together in the form of yolk solids. In the second case, the protein of coral birds and soybean oil were used to provide protein and fat. The dry matter content of the high moisture solid was about 25% and the amount of each of the constituents of the dry matter, based on the weight of the high moisture solid for each formulation, was as indicated in Table 4. Table 4 indicates that cumulative gains and improved cumulative feed efficiencies were observed in all treatments with the formulation. Lipase did not appear to increase the availability of these complex fat sources. The first cumulative feeding uptake, superior was achieved with yolk solids in the absence of additional lipase. It should be noted that the yolk was also used in Example 1, but the response of the birds was not evident in the absence of a source of carbohydrates, salts of bile acid, a source of methionine and added lysine.
TABLE 4 Growth of Birds Fed with Formulations Containing Protein and Fat Sources, with and without Lipase (Corn starch: 2.5%, Alimet: .05%, Lysine .05%, Chenodeoxycholic acid: .02%)
Cp
EXAMPLE 5 Groups of one to four day old birds fed agar (1.5% agar and 98.5% water) and agar plus a direct feeding microbial agent (1.5% agar, 88.5% water, 10% microbial agent of direct feeding Biomate that includes the microbial carrier) were compared to a control in fasting. The direct feeding microbial agent ("DMF") consisted of two species of La ctoba ci l li and two species of Ba ci l l i. The direct feeding microbial agent contained 2.2 x 108 colony-forming units per gram of material for each of the species of La ct oba ci lliy and 5.5 x 108 colony-forming units per gram of material for each of the Bacillus species. lli with each cage of 8 birds that receive 1 gram of the product. Although the cumulative feeding efficiency of this treatment was poorer than that of the agar alone, the cumulative gain seemed to increase in the presence of water and DMF. Therefore, the DMF provided some benefit and to optimize this effect, more nutrients must be added to the high moisture solid.
TABLE 5 Growth of Birds Fed with Agar (1.5%) and Agar Containing a Direct Feeding Microbial Agent Consisting of Lactobacillus acidophilus and Lactis, and Bacillus subtilis and licheniformis (10%)
Lp
EXAMPLE 6 This example shows the response of freshly hatched birds from one to four days of age to casein, casein hydrolyzed with enzymes and casein administered with a source of proteolytic activity. The high moisture solid contained 85% water with the rest of the constituents as indicated in Table 6. In treatment 3, 0.6% pepsin (based on the weight of the high moisture solid) was added to the formulation and in treatment 4, a microbial agent that secretes a proteolytic enzyme was added. All treatments with the formulation showed cumulative gain, cumulative feeding efficiency and higher life expectancy when compared to fasting control.
TABLE 6 Growth of Birds Fed with Formulations with Casein, Hydrolyzed Casein, Casein with Pepsin or Casein with B. licheniformis (2xlOe / bird) (Ground corn: 10%, Agar: .25%, Alimet: .125%, Lysine: .04)
Lp 00
EXAMPLE 7 In this example, birds from zero to two days of age were fed formulations consisting of 10% dry matter in the form of corn starch (2.5%), protein (5%), and glucose (2.5%) ), based on the weight of the high moisture solid. The birds were treated for 24, 48 or 72 hours, to analyze the possibility of treating the birds during the total pre-placement period of approximately 2 days in the incubator and 1 day in transit. All birds treated with the formulation showed greater cumulative gain than fasting birds during an equivalent period. In addition, birds treated with the formulation for 24 and 48 hours also showed higher cumulative feeding efficiencies. The answer seemed to decline at the 72-hour time point. From these data it seems that 10% of dry matter is sufficient to improve the qualities of young birds during a period of 2 days, but that a higher concentration of nutrients may be required by the third day. It should be noted that for each period of time, the life expectancy of the birds fed with the formulation was higher than the fasting controls.
TABLE 7 Growth of Birds Fed with Breeding Formulations Consisting of Maize Starch (2.5%), Porcine Plasma (5%), Agar (.5%), Alimet (.125%), Lysine (.125%), Glucose (2.5%); 10% of Total Dry Material)
or
EXAMPLE 8 In this example, the growth of non-fed chicks was compared, fed solidified formulations with dehydrated egg white, whole egg or guar / xanthan gums, or a simple corn and rice atole. Table 8 shows the qualities of the first birds when they were influenced by the solidified formulations in various forms. Treatment 1 was the control in fasting. The formulation in treatments 2 and 3 consisted of corn flour (15%), corn starch (2%), soybean meal (12%) and either dehydrated egg white (3.6%) or whole egg (20%). ). Treatment 4 had slightly more soybean meal (16%) to compensate for the loss of egg protein and solidified with a combination of guar (.35%) and xanthan (.05%) gums. Treatment 5 was a simple atole of rice (22.5%) and corn (22.5%).
All formulations contained fumaric acid (1%) and propionic acid (.5%) and a premix of vitamin (.1%) and mineral (.05%). Birds one to four days old were weighed
(Table 8, body weight day 0) and were treated with 10 mg / bird of a high moisture solid or fasted for 24 hours. The birds receiving the high moisture solid received one of four high moisture solids designated in Table 8. The birds were then weighed again (body weight day 1) and all were offered water and starter feed for consumption ad libitum As can be seen in Table 8, fasting birds initially lost weight while birds treated with the formulation either maintained or even gained weight. However, the result of day 6 indicated that formulations with higher protein (2-4) were more beneficial than the simple mixture of rice and corn. Both the body weights and the feeding efficiencies of the birds in treatments 2-4 were superior to those of treatment 5. All birds showed an improvement in the first life expectancy compared to fasting controls.
TABLE 8 Growth of Birds Not Fed or Fed with Solidified Formulations with Dehydrated Egg White, Complete Egg or Guar / Xanthan Gums, in Comparison to a Simple Rice and Corn Atole.
EXAMPLE 9 In this example, the water retention characteristics of the various formulations described in Example 8 were compared to those in a simple gruel of rice and ground corn. After 24 hours, the formulations in which egg or gums were added to the water maintained more moisture than the thick, simple suspension with hot water of rice and ground corn. When these were fed to chicks from one to four days of age, it was observed that the birds fed the rice gristle and ground corn were moistened, although no measurable water escaped from any of the mixtures. The results were presented in the Table
TABLE 9 Water Retention (%) in Formulations after 24 hours at 80, 90 or 100 ° C and 40% Humidity
i
EXAMPLE 9a Table 9a shows the loss of water by high moisture solids maintained at 80 ° C and 70% humidity. Formulations 1-4 contained guar and xanthan gums (0.6-1%), 20-22% soybean meal and approximately 16% corn flour, with the rest as water. The levels of humectants ranged from 1 g (modified corn starch) to 50 g (propylene glycol and glycerol). Formulations 5 and 6 were included as examples of simple formulations which did not include a humectant. Formulation 5 consisted of 21% soy flour, 11% oats and 8.5% rice, with the rest as water. Prior to the experiment shown in Table 9a, all formulations were kept at room temperature overnight to allow the mixtures to absorb water. In the absence of a humectant, a gel based on rubber lost 19% in its water in 24 hours and 34% after 48 hours. The high moisture solids containing the propylene glycol and glycerol humectants lost 0-10% of their water in 24 hours and 4-17% after 48 hours. The modified corn starch did not perform as well under these conditions as the other humectants. Simple mixtures of grain and rice retained water under these conditions, losing 24% of water during the first 24 hours and 47-53% of their water for 48 hours.
TABLE 9a Water Retention (80 ° C, 70% Humidity) in 24 and 48 hours by High Moisture Solids Containing Gums or Moisturizers Compared with Simple Blends of Grains, Soybean Meal and Rice
EXAMPLE 10 In this example, the samples of the formulations containing soy flour (12%), corn flour (17%) and either complete egg (20%) or guar gum / xanthan (4%) stabilized with acids fumaric
(1%) and propionic (0.5%) were compared to a simple mixture of corn (23%) and rice (23%) for microbial growth. All mixtures were stored sealed
(except for sampling) at room temperature. Plates were incubated for 3 days at 37 ° C in a saturated atmosphere. MacConkey agar was included to evaluate the growth of Gram negative organisms such as E. Coli. From Table 10 it is clear that the mixture of rice and corn was not stable and supported high levels of microbial growth when stored at room temperature in a sealed bag. The heating procedure did not destroy the spores of bacilli, and these would be the source of the colonies observed in the blood agar on day 1 and 2 in the formulation containing guar and xanthan gums. However, it is clear that the bacilli did not multiply in the formulation itself, because the numbers did not increase with time. The organisms present in the rice and maize atole included Gram-negative rods, Gram-positive cocci and yeast. The formulation made with soy flour
(11%), corn flour (15%), corn starch (2%), dehydrated egg white (6%) and stabilized with citric (1%) and propionic (0.5%) acids were also analyzed for stability to microbial growth. Samples were stored for 9 weeks without showing any indication of microbial growth when analyzed on blood agar and MacConkey agar. There was no obvious mold growth in the samples and there was no indication of water separation from the high moisture solid during this period of time.
TABLE 10 Microbial Growth of a 1: 1000 Dilution of the Formulation or
EXAMPLE 11 This example shows the close analysis of several high moisture solids in comparison with the mixtures of rice and several grains with as much water as the combination will maintain (excess water poured). The values for carbohydrates were obtained by difference. Studies of qualities using live birds have indicated that the optimum level of protein in a high moisture solid supplied as food to one-day-old birds is 10-11%. Using 33% dry matter levels, feeding at a 10% protein level and 20% carbohydrate in a high humidity solid resulted in a gain on day 6 and feed conversion results (Example 8) better than a mixture of rice and corn that contains 4% protein and 35% carbohydrate. A protein level of 10% is not possible using a mixture based on a whole grain and rice or whole grain alone, even with 100% dry matter. Even if the grain were relatively high in protein, such as wheat (15% maximum), protein levels higher than 7-8% would not be possible in a mixture containing 50% water. With a mixture of wheat and water, a protein level of 10.5% would require 70% dry matter. The results are presented in Table 11.
TABLE 11 Next Analysis of Corn and Soybean Flour Formulations and Containing Dehydrated Egg White to Adhere to Water in Comparison to Various Mixtures of Rice, Corn and Water.
co
EXAMPLE 12 The objective of this experiment was to determine the optimum ratio of fat, protein and carbohydrate in a formulation with a composition of 25% solids. An experimental design was generated to comply with the established objective and implemented as a cage 96,
41 days of study. In this study, the 1-4-day-old chicks were fed the formulation and fasted for 48 hours. The results are presented in Figure 1. The quality parameter illustrated in Figure 1 is the estimated feed conversion for a tender chicken of 2 kg in 41 days. A response surface model was made for the conversion of the corrected feed to a constant live weight. It was found that fat had a large negative impact on the qualities. Birds treated with more than 5% fat showed live weight losses and increased feed conversion. The best result for this 25% dry matter formulation occurred with protein and carbohydrate treatments where the birds exhibited corrected feed conversions of body weight of 1.72-1.73. Mortality was lower in 21 days for treatments with higher levels of protein, and higher with treatments that contained significant amounts of fat. The data from this experiment indicate that the optimal, digestible carbohydrate level is above 8%.
Example 13 Premature mortality in poults is a particular problem in this industry. This is attributed to a number of factors, including the failure of birds to ingest food and water ad libitum due to an excessively long time between hatching and laying. In this experiment, groups of one to four day old turkey poults were fed a 33% dry matter formulation containing less than 1% fat, 9-10% protein and 22-23% carbohydrate, or They kept fasting and were deprived of water for either 24 or 48 hours. In a percentage of dry matter bases, the formulation contained 44% corn flour, 6% corn starch, 36% soybean meal, 11% dehydrated egg white, 2% fumaric acid, and 1.5% of propionic acid. As a percentage of the total formulation, this was equal to 15% corn flour, 2% corn starch, 12% soybean meal, 3.6% dehydrated egg white, 0.7% fumaric acid, and 0.5% of propionic acid. Then, the birds were given a conventional feeding formulation. As shown in Figure 2, the qualities of the birds in this regimen showed differences in cumulative mortalities on days 7, 14, 21: fasting birds for 24 hours showed greater mortalities than those given the formulation during 24 hours. hours. This was further accentuated when the birds fasted or were given the formulation for 48 hours. In the group fasting for 48 hours, premature mortality reached almost 20% by day 21, while the birds were given the formulation during the same time period they showed the lowest cumulative mortality in 21 days in the study, ie , less than 10%.
EXAMPLE 14 This experiment was performed to analyze the effect of feeding the high moisture material of the present invention to fresh hatched birds before they are offered dry feed ad libitum containing approximately 77% water, 1% fat. , 11% carbohydrate and 11% protein, on the resistance of chickens to a disease challenge with or without previous vaccination for the pathogen. (The same basic composition was also used in the examples that follow). The term "disease provocation" refers to the contact of poultry with a pathogenic agent, causing a negative effect on a parameter of qualities such as health, life expectancy, weight gain or efficient conversion of food. The treatments 1-4 did not receive food or water, while the high humidity material (designated "1027" in Figure 3) was the only source of nutrition and hydration during the first two days of the experiment for treatments 5-8. A dose of oral immunization of a coccidial vaccine (CocciVac®, Ster in Laboratories) was given to birds in treatments 2, 4, 6 and 8 on day 0. Birds in treatments 1, 3, 5 and 7 they received orally an equal volume of saline at that time. All birds were fed the same food and water ad libitum subsequent to day 2 after hatching. On day 14, birds were administered in treatments 3, 4, 7 and 8 a very high dose of coccidia (lOOx / lOOg body weight of CocciVac®), enough to affect the qualities of birds both natural and immunized. Figure 3 shows the cumulative gain of these birds on day 21. Compared to fasting, feeding with the present high humidity material was associated with a significantly higher gain in unvaccinated, unprovoked birds (treatment 1 versus treatment 5) , vaccinated birds, unprovoked (treatment 2 against treatment 6), unvaccinated birds, provoked (treatment 3 against treatment 7), and vaccinated birds, provoked (treatment 4 against treatment 8). In this way, feeding with the high humidity material not only improved the ability of unvaccinated birds to resist disease provocation, but also resulted in superior qualities of the vaccinated, provoked birds (treatment 8) when compared to their fasting controls (treatment 4). These data show that feeding the high moisture solid to newly hatched birds improved the general qualities of the birds and their ability to respond to a disease challenge as exemplified by the qualities of each of the groups they receive. the high humidity material compared to its fasting control.
EXAMPLE 15 This example shows the results of an experiment in which the chickens were fed the high moisture material as the sole source of nutrition and hydration during the first two days of the experiment. During these two days, adjuvant birds were also administered variously consisting of (as a percentage of dry matter) muramyl dipeptide (0.015%), mannan (0.06%), dead yeast cells (0.15%), dead bacteria (Propi oniba ct eri um a cnés, 0.03%), saponin (0.3%), levamisole (0.005%), and vitamins A (0.0001%) and E (1.5%), or saline (0.01%). All birds were given a common diet following this initial two-day treatment period, and were orally vaccinated with CocciVac coccidial vaccine on day 0 following manufacturers' instructions. The data in Figure 4 show the effect of the various adjuvants on bag weight as a percentage of body weight on day 7. Clearly, several of the adjuvants were associated with a relatively heavier bag weight than in birds fed with high humidity material (designated 1027) only. Since the weight of the relatively heavier bag is associated with disease resistance, these data suggest that the addition of an adjuvant to the high moisture material, in association with vaccination, can improve the ability of the birds to resist the agents pathogens and other stresses.
EXAMPLE 16 This example demonstrates the effect of the same adjuvants, in the same amounts, used in Example 15 on the amount of IgA in the bile of the chickens, 21 days after the vaccine and the adjuvants were administered orally. IgA is the class of antibody associated with resistance to diseases that attack the intestinal mucosa, such as coccidiosis. The data presented in Figure 5 were obtained by the enzyme-linked immunosorbent assay, indirect (ELISA) using mouse IgA, monoclonal, anti-chicken as the first antibody, goat IgA, polyclonal, anti-chicken as the second antibody and anti-goat immunoglobulin conjugated with biotin for detection. Samples were read on an automated ELISA plate reader and corrected for differences in dilution. The data showed that the adjuvants contained in the high moisture material (1027) were active when administered orally, and stimulated the mucosal immune system specifically and differentially. Some, for example, treatment 5 (Propi on was used to kill), resulted in a significantly higher bile IgA content 21 days after administration of the high moisture material with the adjuvant and the vaccine. These results suggest that the high moisture material of the present invention can be used for the oral delivery of effective adjuvants in the stimulation of the mucosal immune system in poultry. This may result in the stimulation of the production of specific antibodies to, or associated with, the mucosal immune system, including the intestines, respiratory system, genital-urinary system, reproductive system and lacrimal system. This may also include the stimulation of lymphocytes or cytokines characteristic of cell-mediated immunity.
EXAMPLE 17 A series of experiments was carried out on chickens fresh from the shell in which the high moisture material (designated "1027" in Figure 6) was administered with or without an adjuvant for two days after hatching, then of which half of the birds were provoked with an oral dose of coccidia oocysts (CocciVac® used at 100 times the vaccination dose) two weeks later. The unchallenged birds were given either the high moisture material (1027) or the high moisture material containing vitamin A (0.015% dry matter) and vitamin E (0.27% dry matter) (1027AE) were used as controls. The data in Figure 6 present the results of this study, designed to evaluate the effects of vitamins A and E as adjuvants when they were given in the high humidity material during a period of two days after hatching. The gain and feed efficiencies of the controls without causing were the same 21 days after treatment with either 1027 or 1027AE (the first two groups of bars). The qualities of the birds that were given the provocation of coccidia on day 15 were compared with those of the control birds. It is clear that the provocation affected both the efficiency of gain and feeding. However, the gain of the birds that were given 1027 and then caused by coccidia is lower than that of the birds that were given the 1027AE and caused by coccidia. In addition, feed conversion is poorer for birds that were given 1027 pure than those treated with 1027 plus an adjuvant and subsequently triggered. It seems that the presence of vitamins A and E in the high humidity material resulted in birds more able to resist an immune, oral tension (provocation with coccidia) two weeks later.
EXAMPLE 18 Another example of the effects of an adjuvant is shown in Figure 7. In this experiment, the qualities of the birds fed the high moisture material containing the adjuvants Concanavalin A (0.001% dry matter) and levamisole (0.0005 % of dry matter) (designated 1027CL) were compared with those of birds fed with high moisture material alone (1027). It is believed that Concanavalin A and levamisole are stimulators specifically for T lymphocytes. As shown in Example 16, levamisole resulted in higher levels of bile IgA in 21 days when given individually. In this experiment, chickens fresh out of the shell were induced with a coccidial strain on day 14 after administration of the high moisture material. To the birds without causing that they were given the high humidity material alone (1027) or the high humidity material that contains Concanavalin A and levamisole
(1027CL) served as controls.
The data in Figure 7 show that the presence of adjuvants in the high moisture material (1027CL) administered on days 0 and 1 was associated with a significantly higher cumulative life expectancy after challenge with coccidia and a feeding relationship to gain numerically superior during a period of 7 days immediately after the provocation than in the birds fed with the high humidity material (1027) alone. The two treatments did not result in differences between the control groups without causing. As in Example 17 above, the birds that exhibited a benefit of Concanavalin A and levamisole were not previously exposed to a coccidial vaccine, but they were unaffected at challenge on day 14.
EXAMPLE 19 In this experiment, freshly hatched chickens were given bacterial, dead cells of Propi on iba teri um spp (0.06% dry matter) and Sa lmonel l a ssp (0.06% dry matter). As shown in Examples 15 and 16, an oral dose of
Propa ons were killed in birds vaccinated for coccidiosis resulting in both bag weight and relatively higher bile IgA levels than in the birds given the high moisture material alone. Similar results were observed with dead cells of Sa lmonella (data not shown). In this example, the dead cells of both bacteria were administered in the high humidity material on days 0 and 1 of the study. In addition, half of the birds were given a dose of CocciVac immunization on days 0 and 1, and a booster dose was given on day 7 (vaccinated). Vaccination in the presence of adjuvants was associated with the poorer qualities of day 14, presumably due to the strong immune response, and data were covaried for body weight on day 14 in Figure 8. All birds were caused with coccidia on day 14. The data shown in Figure 8 indicate that the presence of adjuvants was associated with improved body weight after challenge in both the control and vaccinated birds. In the case of birds vaccinated prior to challenge, the presence of the adjuvant resulted in significantly higher body weights after challenge, indicating an improved response to the vaccine when administered in association with the oral adjuvant given in the 1027 high moisture material. Life expectancy was not affected by any of the treatments in this experiment.
Example 20 This example demonstrates the effect of texture and color on the ingestion of high moisture material by turkeys fresh from the shell. The texture agent used was millet. The poults were offered high colored and textured moisture material for a period of approximately 12 hours. As shown in Figure 9, both the appearance and the texture of the high humidity material influence the ingestion by the birds. In view of the above, it will be noted that several objects of the invention are carried out. As several changes could be made to the above compositions and processes without departing from the scope of the invention, it is proposed that all material contained in the above description be construed as illustrative and not in a limiting sense.
It is noted that in relation to this date, the best method known to the applicant to carry out the aforementioned invention, is that which is clear from the present description of the invention.
Having described the invention as above, the content of the following claims is claimed as property.
Claims (50)
1. A process for increasing health, life expectancy, weight gain or feed conversion efficiency of poultry, the process is characterized in that it comprises feeding a high moisture material containing at least about 20% by weight of feed. water and an additive selected from the group consisting of a coloring agent, an adjuvant, a flavor modifier, and a combination thereof to the poultry before dry feed ad libitum is offered to the poultry.
2. The process according to claim 1, characterized in that the coloring agent is red, blue, green, blue-green, black or beige.
3. The process according to claim 1, characterized in that the flavor modifier is selected from the group consisting of grains of sand, oyster shell, whole seeds or grains.
4. The process according to claim 1, characterized in that the adjuvant is selected from the group consisting of material obtained from a microorganism; A virus; a lectin; a polysaccharide; an oily emulsion; a peptide, polypeptide, or protein, and a nucleic acid.
5. The process according to claim 4, wherein the material obtained from a microorganism selected from the group consisting of a bacterial lysate, 6,6-diester of trehalose, a synthetic analogue of a 6,6-diester of trehalose, muramyl dipeptide, a synthetic analogue muramyl dipeptide, an L-seryl of muramyl dipeptide, an L-valyl of muramyl dipeptide, killed bacteria, soluble mitogen water Noca rdi to, components of the cell wall of S taphyl ococcus, bestatin, dead yeast, zymosan, glucan, lentanina, endotoxin, an enterotoxin a peptidoglycan bacterial cell wall and bacterial ribonucleoprotein.
6. The process according to claim 5, characterized in that the bacterial lysate is prepared from a bacterium of the genus Haemophilus, Diplococcus or Neisseria.
7. The process according to claim 5, wherein the killed bacteria are selected from the group consisting of spp Escherichia, Clostridia spp, Salmonella spp, Lactobacillus spp, Streptococcus spp, Bacillus Calmette-Guerin, Mycobacterium spp, Bordetella spp, Klebsiella spp, Brucella spp, Propionibacterium spp, Pasteurella spp, and dead Nocardia spp.
8. The process according to claim 5, characterized in that the dead yeast is selected from the group consisting of Saccharomyces spp and dead Candida spp.
9. The process according to claim 4, characterized in that the virus is selected from the group consisting of an Avipoxvirus and a Parapoxvirus.
10. The process according to claim 4, characterized in that the lectin is selected from the group consisting of concanavalin A, mitogen of carmine or grana herb and phytohemagglutinin.
11. The process according to claim 4, wherein the polysaccharide is selected from the group consisting of a mannan, carrageenan, iota carrageenan, one hemicellulose, one levan, agar, tapioca, a dextran, a dextrin, and a lipopolysaccharide.
12. The process according to claim 4, characterized in that the oily emulsion comprises an oil selected from the group consisting of mineral oil, peanut oil, and sesame oil.
13. The process according to claim 4, wherein the peptide, polypeptide or protein is selected from the group consisting of an interferon, an inducer of interferon, a cytokine, thymic hormone, a protease inhibitor, a chemotactic factor, tuftsin, and serum albumin.
14. The process according to claim 4, characterized in that the nucleic acid is selected from the group consisting of a nucleic acid digestive substance, a double-stranded complementary RNA homopolymer, and immune RNA.
15. The process according to claim 1, characterized in that the adjuvant is selected from the group consisting of a saponin, thiabenedezol, tilorone, estatolone, maleic anhydride-divinyl ester, a pyran copolymer, amphotericin B, a liposome, silica, phosphate calcium, glycerol, betaine, proto-dine, cyanidanol, imutiol, picibanil, isoprinosine, lentinan, azimezon, a lecithin, levamisole, a retinol, a tocopherol, an antioxidant, an aluminum salt, aluminum hydroxide and aluminum oxide.
16. The process for increasing the resistance of poultry to a challenge of disease or other stress, the process is characterized in that it comprises feeding a high moisture material containing: between about 50% and 80% by weight of water; at least about 10% by weight of carbohydrate; a nitrogen-containing member selected from the group consisting of protein, amino acids, amino acid precursors, amino acid analogues and combinations thereof; wherein the carbohydrate ratio to the nitrogen-containing member is in the range between about 1: 1 and about 3: 1, to the poultry before dry feed ad libitum is offered to the poultry.
17. The process according to claim 16, characterized in that the high moisture material contains: between about 50% and about 80% by weight of water; at least about 10% by weight of carbohydrate; and a member selected from the group consisting of: at least about 5% by weight of protein, at least about 7% by weight of amino acids, amino acid precursors, amino acid analogues or a combination thereof, a combination of at least about 5% by weight of protein and at least about 5% by weight of amino acids, amino acid precursors, amino acid analogs or a combination thereof, a combination of at least about 10% by weight of protein, amino acids, amino acid precursors and amino acid analogs, and at least about 10% by weight protein.
18. The process for increasing the resistance of poultry to a challenge of disease or other stress, the process is characterized in that it comprises feeding a high moisture material containing: an adjuvant; between about 50% to 80% by weight of water; at least about 10% by weight of carbohydrate; and a nitrogen-containing member selected from the group consisting of protein, amino acids, amino acid precursors, amino acid analogs and combinations thereof; wherein the carbohydrate ratio to the nitrogen-containing member is in the range between about 1: 1 and about 3: 1, to the poultry before dry feed ad libitum is offered to the poultry.
19. The process according to claim 18, characterized in that the high moisture material contains: between about 50% and about 80% by weight of water; at least about 10% by weight of carbohydrate; a member selected from the group consisting of: at least about 5% by weight of protein, at least about 7% by weight of amino acids, amino acid precursors, amino acid analogs or a combination thereof, a combination of at least about 5% by weight % by weight of protein and at least about 5% by weight of amino acids, amino acid precursors, amino acid analogues or a combination thereof, a combination of at least about 10% by weight of protein, amino acids, amino acid precursors and the like of amino acids, and at least about 10% by weight of protein.
20. The process according to claim 16, characterized in that it also comprises administering a vaccine to poultry.
21. The process according to claim 18, characterized in that it also comprises administering a vaccine to poultry.
22. The process according to claim 18, characterized in that the adjuvant is selected from the group consisting of material obtained from a microorganism; A virus; a lectin; a polysaccharide; an oily emulsion; a peptide, polypeptide or protein; and a nucleic acid.
23. The process according to claim 22, characterized in that the material obtained from a microorganism is selected from the group consisting of a bacterial lysate, a 6,6-diester of trehalose, a synthetic analog of a 6,6-diester of trehalose, muramyl dipeptide, a synthetic analogue of muramyl dipeptide, an L-seryl derivative of muramyl dipeptide, an L-valyl derivative of muramyl dipeptide, dead bacteria, water soluble mitogen Noca rdia, cell wall components of Staphyl ococcus, bestatin, dead yeast, zymosan, glucan, lentonin, an endotoxin, an enterotoxin, a peptidoglycan from the bacterial cell wall and a bacterial ribonucleoprotein.
24. The process according to claim 23, characterized in that the bacterial lysate is prepared from a bacterium of the genus Ha emophi lus, Dipl ococcus or Nei sseria.
25. The process according to claim 23, characterized in that the killed bacteria are selected from the group consisting of Escheri chi a spp, Cl tridia spp, Salmonella spp, Ctoba ci ll us spp, Streptococcus spp, Ba ci ll us Calmet te- Guerin, Mycoba cteri um spp, Bordetella spp, Klebsiella spp, Brucella spp, Propioniba cterium spp, Pas terurella spp, and Noca rdia spp.
26. The process according to claim 23, characterized in that the dead yeast is selected from the group consisting of Sa ccha romyces spp and Candi da spp dead.
27. The process according to claim 22, characterized in that the virus is selected from the group consisting of an Avipoxvirus and a Parapoxvirus.
28. The process according to claim 22, characterized in that the lectin is selected from the group consisting of concanavalin A, mitogen of carmine grass or grana and phytohemagglutinin.
29. The process according to claim 22, characterized in that the polysaccharide is selected from the group consisting of a mannan, carrageenan, iota carrageenan, a hemicellulose, a levan, agar, tapioca, a dextran, a dextrin, and a lipopolysaccharide.
30. The process according to claim 22, characterized in that the oily emulsion comprises an oil selected from the group consisting of mineral oil, peanut oil, and sesame oil.
31. The process according to claim 22, characterized in that the peptide, polypeptide or protein is selected from the group consisting of an interferon, an interferon inducer, a cytokine, a thymic hormone, a protease inhibitor, an iotactic qui factor, tuftsin , and serum albumin.
32. The process according to claim 22, characterized in that the nucleic acid is selected from the group consisting of a nucleic acid digestive substance, a complementary double-stranded RNA homopolymer, and immune RNA.
33. The process according to claim 18, characterized in that the adjuvant is selected from the group consisting of a saponin, thiabenedezol, tilorone, estatolone, maleic anhydride-divinyl ester, a pyran copolymer, amphotericin B, a liposome, silica, phosphate calcium, glycerol, betaine, proto-dine, cyanidanol, imutiol, picibanil, isoprinosine, lentinan, azimexon, a lecithin, levamisole, a retinol, a tocopherol, an antioxidant, an aluminum salt, aluminum hydroxide and aluminum oxide.
34. The process for stimulating the mucosal immune system in poultry, the process is characterized in that it comprises feeding a high moisture material containing: an adjuvant; between about 50% and 80% by weight of water; at least about 10% by weight of carbohydrate; and a nitrogen-containing member selected from the group consisting of protein, amino acids, amino acid precursors, amino acid analogs and combinations thereof; wherein the carbohydrate ratio to the nitrogen-containing member is in the range between about 1: 1 and about 3: 1, to the poultry before dry feed ad libitum is offered to the poultry.
35. The process according to claim 34, characterized in that it also comprises administering a vaccine to poultry.
36. A high moisture material to increase health, life expectancy, cumulative weight gain, feed conversion efficiency, resistance of poultry to a challenge of disease or other stress, or to stimulate the immune response associated with the intestines in poultry, characterized in that it contains: at least about 20% by weight of water; at least about 8% by weight of carbohydrate; at least about 7% by weight of an amino acid source; and an additive selected from the group consisting of an uptake regulator or flavor modifier, an adjuvant, and mixtures thereof, wherein: the uptake or flavor modifier is different from a gum, an amino acid, a coloring agent or a fish oil; the adjuvant is different from calcium phosphate, an oily oil or emulsion, the dead ctoba cill, or a vitamin; and the high humidity material does not release free water in an amount sufficient to wet newly hatched birds as a consequence of their coming into contact with it.
37. The high moisture material according to claim 36, characterized in that the high moisture material contains between about 60% and about 80% by weight of water.
38. The high moisture material according to claim 36 or 37, characterized in that the taste regulator or picker is selected from the group consisting of grains of sand; oyster shell; whole seeds or grains; a triglyceride; fish flour; a spice; clonidine; a gastrin antagonist; a cholecystokine antagonist; naloxone; pancreatic polypeptide; norepinephrine; a melatonin antagonist; a hormone of the thyroid; and pentobarbital.
39. The high moisture material according to claim 36 or 37, characterized in that the adjuvant is selected from the group consisting of a microbiologically derived substance; A virus; a lectin; a polysaccharide; a peptide, polypeptide, or protein; and a nucleic acid, wherein the polysaccharide, peptide, polypeptide or protein is orally effective in poultry as an adjuvant to stimulate the immune system and / or to increase the resistance of poultry to pathogens or other stresses.
40. The high moisture material according to claim 39, characterized in that the microbiologically derived substance is selected from the group consisting of a lysate of bacteria; a 6,6-diester of trehalose; muramyl dipeptide, N-acetyl-muramyl-L-alanyl-D-isoglutamine; an L-seryl or L-valyl derivative of muramyl dipeptide; dead bacteria and derivatives thereof; a product of the cell wall of Staphyl ococcus; bestatin; dead yeast; a yeast derivative; an endotoxin; an enterotoxin; a peptidoglycan of the cell wall; and a bacterial ribonucleoprotein.
41. The high moisture material according to claim 39, characterized in that the virus is selected from the group consisting of an Avipoxvirus and a Parapoxvirus.
42. The high moisture material according to claim 39, characterized in that the lectin is selected from the group consisting of concanavalin A, mitogen of carmine grass or grana and phytohemagglutinin.
43. The high moisture material according to claim 39, characterized in that the polysaccharide is selected from the group consisting of a mannan, an acetylated mannan bonded with β- (1,4); an oligosaccharide of mannan, a glucan; a hemicellulose, a levan, a dextrin, a dextran; and a lipopolysaccharide.
44. The high moisture material according to claim 39, characterized in that the peptide, polypeptide, or protein is selected from the group consisting of a cytokine, an interleukin; Transfer factor; Macrophage Activation Factor; Inhibitory Factor of Migration; a mitogenic factor for lymphocytes; interferon;, an interferon inducer; a typical hormone; a protease inhibitor, a chemotactic factor for macrophages and other cells; Tuftisin and serum albumin.
45. The high moisture material according to claim 39, characterized in that the nucleic acid is selected from the group consisting of a digestive substance of nucleic acid, a complementary double-stranded RNA homopolymer, and immune RNA.
46. The high moisture material according to claim 36 or 37, characterized in that the adjuvant is selected from the group consisting of a saponin; thiabenedezol; tilorone; estatolone; maleic anhydride-divinyl ester; a pyran copolymer; amphotericin B; a liposome; silica; glycerol; betaine; protodine; cyanidanol; imutiol; picibanil; isoprinosine; lentinan; azimexon; lecithin; levamisole; an antioxidant; an aluminum salt; aluminum hydroxide; aluminum oxide; and saline solution.
47. A high moisture material to increase health, life expectancy, cumulative weight gain, feed conversion efficiency, resistance of poultry to a provocation of disease or other stresses, or to stimulate the immune response in birds of farmyard, characterized in that it contains: at least about 20% by weight of water; at least about 8% by weight of carbohydrate; at least about 7% by weight of an amino acid source; an acid stabilizer; and a coloration of the blue-green food, where the high humidity material does not release free water in an amount sufficient to moisten the newly hatched birds as a consequence of coming into contact with it.
48. The high moisture material according to claim 47, characterized in that the high moisture material contains about 60% to about 80% by weight of water.
49. The high moisture material according to claim 47 or 48, characterized in that the carbohydrate is a mixture of ground corn and corn starch, and the source of amino acids is a mixture of soy food and eggs without shell.
50. The high moisture material according to any of claims 36 to 49, characterized in that it is in the form of an extruded material.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08760881 | 1996-12-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA99005029A true MXPA99005029A (en) | 2000-04-24 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU729057B2 (en) | High moisture nutrient formulation for poultry | |
US5985336A (en) | Nutrient formulation and process for feeding young poultry and other animals | |
US5928686A (en) | Nutrient formulation and process for feeding young poultry and other animals | |
US10398156B2 (en) | Animal feed compositions and feed additives | |
US20150173397A1 (en) | Pet food composition having probiotic bifidobacterium animalis | |
Bidura et al. | Implementation on diet of probiotic Saccharomyces spp. SB-6 isolated from colon of Bali cattle on egg production and egg cholesterol concentration of Lohmann brown laying hens | |
EP0914778A1 (en) | Oral administration of bacteria at a concentration which produces cell-mediated immunity and weight in certain animals | |
Agboola et al. | Influence of dietary supplementation of probiotics and symbiotics on growth performance, nutrient digestibility and organ weights in turkey poults | |
WO2001091574A2 (en) | Particulate feed for young poultry | |
MXPA99005029A (en) | High moisture nutrient formulation for poultry | |
AU5460199A (en) | Feed withdrawal compositions and methods | |
Kavazović et al. | Učinci testne mješavine i komercijalnog probiotika na proizvodna svojstva brojlera | |
El-Katcha et al. | Impact of Dietary Supplementation of Probiotic and/or Prebiotic on Performance and Immune Response of Japanese Quail | |
Ariyadi | The effects of single lactic acid bacteria probiotic supplementation on intestinal mucosa profile and immune response in broilers | |
Gunaratne | A REVIEW OF USE OF PROBIOTIC AS GROWTH PROMOTER IN ANIMAL FEEDING | |
Nyachoti | Nonruminant Nutrition: Bioactive Compounds and Prebiotics in Swine Nutrition |